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ABSTRACT 
Cognitive assessments were conducted on aircraft crew who reported 
symptoms following exposure to jet oil engine emissions from BAe-
146 aircraft.  Results demonstrated impairments on tests of reaction 
time, processing speed and fine motor skills in most participants.  
Findings were significant but with such a small sample this may not 
be representative.  However if extrapolated across the aviation 
industry, could indicate significant aviation safety problems.  The 
possibility of consistent neuropsychological impairments with 
exposure to jet engine emissions indicates a need for more robust 
studies. 
A second study investigated the psychological impact on spouses of 
aircraft maintenance engineers affected by the toxic chemicals used 
in the Deseal/Reseal program of F-III aircraft. 
Ninety one spouses of affected RAAF workers were administered the 
Personality Assessment Inventory (PAI); Zarit Burden Interview (ZBI); 
and Spouse Questionnaire (SQ).  Controls were twenty five aged 
matched spouses of RAAF personnel not involved in the program. 
Results demonstrated significant differences between experimental 
group and controls on PAI Somatic Complaints, Anxiety, Depression, 
and Stress scales.  Spouse Questionnaire of coping skills, 
demonstrated that the experimental group had significant difficulties 
coping with spouses.  ZBI administered to experimental group only, 
indicated that their burden of stress was moderate to severe.    ii 
Despite limited control group, results were considered significantly 
robust and statistically significant, which suggested it unlikely that 
results would have been different, given a larger sample. 
In the final study cognitive assessments were conducted on forty two 
health care workers exposed to the chemical glutaraldehyde.  Workers 
were divided into two experimental groups: EXP1, currently working 
with glutaraldehyde, with protective measures;  EXP2, previously 
worked with glutaraldehyde with poor protection.  Controls were 
eighteen age matched health care workers, not exposed to 
glutaraldehyde. 
All groups were administered the Hospital Anxiety and Depression 
Scale (HADS) for emotional impact of chemical exposure.  Results 
indicated significant impairments in information processing speed, 
reaction time and accuracy of responses in experimental groups 
compared with controls.  Differences were more significant in the 
extensively exposed EXP2 group, who also had higher elevations on 
the depression scale of the HADS. 
Results demonstrated significant neuropsychological and emotional 
effects in individuals extensively exposed to glutaraldehyde, using 
few protective measures, compared with less severely exposed 
workers or controls.  Implications of test results and importance of 
adherence to health and safety regulations are discussed. 
If extrapolated across the health care professions this could indicate 
occupational health and safety issues in hospitals and clinics, where 
chemicals are used.   iii 
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CHAPTER  1 
Introduction and Literature Review 
1.1  Overview of the Chapter 
The first section reviews the historical background of neurotoxic substances and 
incorporates the accumulation of knowledge regarding the adverse effects of 
neurotoxins on the human body.  It also outlines the effects of neurotoxins on 
the functioning of the human brain.  The classification of neurotoxins and their 
specific neuropsychological and neurological effects are discussed and 
occupations which are considered to be at risk are outlined.  The legislation 
which has been passed to monitor use of industrial chemicals is also 
documented and discussed. 
 
The second section outlines the extent of the problem for workers in 
occupational settings where they are exposed to neurotoxic chemicals on a 
regular basis.  The requirements for safety measures to protect workers, which 
are not always acknowledged or implemented in many workplaces, will also be 
discussed.  The long term and accumulative effects of chemical exposure will 
be outlined. 
 
The final section outlines the aims and purposes of the present studies.  It will 
document and describe any deleterious effects on the cognitive and emotional 
functioning of aircraft flight crew and health care workers who are exposed to 
neurotoxic chemicals in their workplaces.  It will also address the impact on the 
spouses of aircraft maintenance engineers who were adversely affected by 
neurotoxic exposure in the course of their work.  
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1.2  Historical Background of the Effects of a Range of Neurotoxic 
Substances on Workers in Different Workplace Settings 
1.2.1  Organic Solvents 
Organic solvents are chemicals used for extracting, dissolving or suspending 
materials not soluble in water.  Such materials are fats, resins, oils, lipids, 
cellulose derivatives, waxes, plastics and polymers.  Most solvents are liquids 
and their chemical composition may be simple, comprising a simple chemical 
substance like carbon tetra chloride, or they may be complex, comprising a 
mixture of chemical substances, which can sometimes be quite variable like 
those derived from petroleum (Hartman, 1995). 
 
Over the 100 years since solvents were first produced, evidence has accrued 
suggesting their involvement in neurotoxic syndromes.  It is estimated that 
approximately 10 million workers in United States of America are exposed to 
solvents on a daily basis, which suggests a sizable population at risk for 
neurotoxic exposure effects (Hartman, 1995). 
 
Workers such as house painters, machine degreasers, printers and boat 
builders are among those exposed to organic solvents, like mineral turpentine, 
degreasers and glues, on a daily basis.  These materials can enter the body by 
skin absorption, by inhalation or ingestion (Williams & Lees-Hadley, 1996; 
Baker, 1994; Edling et al., 1990). 
 
Because solvents are lipophilic and pass through fat rich neuronal tissue, 
exposure to these chemicals has been implicated in a wide variety of  
  3 
neuropsychological symptoms.  Among these symptoms are; learning and 
memory difficulties; perceptual and information speed slowing; visuo spatial 
skills deficits; and psychomotor dysfunction (Singer, 1990; Ryan, Morrow, & 
Hodgeson, 1988; Spencer & Schaunburg, 2002; Morrow, Stein, Bagovich, 
Condray & Scott, 2001; Lezak, 2004). 
 
However a number of studies reporting cognitive deficits following solvent 
exposure have been criticized on methodological grounds.  Some researchers 
have identified weaknesses in solvent studies which included:  selection bias in 
recruiting research participants; variability in tests selected to assess 
neurobehavioural functioning; between study variability in the solvents 
examined and the neurobehavioural deficits reported; over-reliance on subject 
recall in establishing pre-morbid functioning; failure to demonstrate dose 
response relationships; failure to control for potential confounders, such as 
education gender and psychiatric function; and small but statistically significant 
findings of doubtful clinical significance (Williams & Lees-Haley, 1996; Fiedler, 
1996; Lees-Haley, 1997). 
 
In 1996 Fiedler briefly reviewed neuropsychological tests which have been used 
to evaluate the effects of neurotoxicants.  She identified factors which may 
heighten sensitivity to neurotoxins and discussed test parameters which would 
increase the sensitivity of neuropsychological tests in low level exposures.  In 
conclusion Fiedler stated that the detection of behavioural performance 
decrements among susceptible individuals, such as those with multiple  
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chemical sensitivity will require more difficult tests than those used in current 
neuropsychological test batteries (Fiedler, 1996). 
 
1.2.2  Acute Exposure to Solvents 
During and immediately following acute exposure to solvents and related 
organics, individuals may complain of headaches, dizziness, undue fatigue, 
nausea mental confusion or ataxia.  Others may have respiratory symptoms or 
skin irritations.  Solvents which cause these problems may include glues, 
paints, marking pens, thinners and degreasers (Anger, 1992; Hartman, 1995; 
Lezak, 2004). 
 
Specific cognitive deficits have been found among individuals exposed acutely 
to solvents in their workplace.  Such workers have been found to have deficits 
in speed of information processing, co-ordination, concentration and vocabulary 
tasks (Chang & Dyer, 1995; Hartman, 1995; Costa & Manzo, 1998; Nilson et al., 
1996). 
 
The severity of dysfunction tends to be associated with the duration and 
intensity of exposure to the solvent.  However, the effects of exposure to many 
organic chemicals is qualitatively similar, the toxic potential of each chemical, as 
measured by their individual exposure standards, can vary substantially. 
 
Table I outlines a clinical diagnostic system integrating reversibility of findings 
and type of function, with DSM-III terminology for acute exposure to solvents 
(White et al., 1992a,  as cited by Chang & Dyer, 1995).  
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TABLE  I 
I  ACUTE  ORGANIC  MENTAL  DISORDERS 
A.  Acute intoxication 
1.  Duration:  minutes to hours 
2.  Residua:  none 
3.  Symptoms:  CNS depression, psychomotor or attentional deficits 
B.  Acute toxic encephalopathy 
1.  Symptoms:  confusion, coma seizures 
2.  Pathophysiology:  cerebral oedema, CNS capillary damage, 
  hypoxia 
3.  Residua:  permanent cognitive deficit may occur 
  (White et al., 1992a,  as cited in Chang & Dyer, 1995) 
 
Studies of the cognitive effects of acute low dose and short-term exposures to 
solvents have identified laboratory tests of attention and monitoring as being the 
most sensitive to this type of exposure, but many of the most sensitive clinical 
tests have not been used in laboratory research on neurotoxins (Anger, 1992; 
Lezak, 1995 & 2004). 
 
1.2.3  Chronic Exposure to Solvents 
Most chronic solvent toxicity occurs in the workplace as a result of exposure to 
fumes from such substances as paints, glues and cleaning fluids (e.g. toluene, 
perchlorethylene and solvent mixtures).  Other toxic solvents commonly found 
in the workplace are petroleum fuels, lubricating and degreasing agents, and 
chemicals used in the manufacture of plastics.  
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Table II outlines a clinical diagnostic system for chronic organic mental 
disorders. 
TABLE  II 
II  CHRONIC  ORGANIC  MENTAL  DISORDERS 
A.  Organic affective syndrome 
1.  Symptoms:  mood disturbance (depression, irritability, fatigue, 
anxiety) 
2.  Duration:  days to weeks 
3.  Residua:  none 
B.  Mild chronic toxic encephalopathy 
1.  Symptoms:  fatigue, mood disturbance, cognitive complaints 
2.  Course: insidious onset, duration: weeks 
3.  Cognitive deficits: may include attentional impairment, motor 
slowing or in-coordination, visuo-spatial deficits, short-term 
memory loss 
4.  Residua:  improvement may occur in absence of exposure, but 
permanent mild cognitive deficits can be seen 
C.  Severe chronic toxic encephalopathy 
1.  Symptoms:  cognitive and affective change sufficient to interfere 
with daily living 
2.  Cognitive deficits:  same as in mild chronic toxic 
encephalopathy, but more severe 
3.  Neurological deficits:  abnormalities seen on some 
neurophysiological or neuroradiologic measures {e.g., 
computed tomography (CT), electromyography (EMG),  
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magnetic resonance imaging (MRI), and electroencephalogram 
(EEG) 
4.  Course:  insidious onset, irreversible 
5.  Residua:  permanent cognitive dysfunction 
  (White et al., 1992a,  as cited in Chang & Dyer, 1995) 
 
Among the subjective complaints of workers exposed to the above chemicals 
are:  fatigue, memory and concentration difficulties, mood changes, depression, 
anxiety, social withdrawal, sleep disturbances and both sensory and motor 
symptoms involving the extremities (Gronwall, 1997; Haut et al., 1999). 
In a number of studies of individuals exposed on a long-term basis to solvents, 
abnormal EEG patterns and brain atrophy have been found (Kilburn, 1994; 
Varney et al., 1998). 
 
Other studies by Ford demonstrate chromosome abnormalities in human 
lymphocytes which were thought to reflect exposure to chemicals (Ford, 1998 & 
1999). 
 
Long-term exposure can also lead to lowered cerebral blood flow, particularly in 
the fronto-temporal areas (Hagstadius, Orback, Risberg & Lindgren, 1989). 
 
Maximilian et al., investigated 32 industrial workers who were exposed to 
organic solvents over an average of 24.5 years, compared with controls.  
Significant correlations were found between age, length of exposure and 
regional cerebral blood flow (rCBF) levels.  The results indicated the potential of  
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the rCBF method for elucidating functional cortical changes related to 
neurotoxic effects of organic solvents (Maximilian et al., 1982). 
 
According to White and Proctor, chronic exposure to solvents can be associated 
with permanent cognitive changes, which can include attentional capacity, 
executive function, visuo-spatial skills, short term memory and mood or affect 
(White & Proctor 1997). 
 
Sensory and motor changes can include impaired visual acuity, impaired colour 
vision, altered sense of smell and hypersensitivity to common environmental 
odours.  Dick and Semple et al reported neurological deficits in solvent exposed 
painters, which included impaired colour vision, cognitive deficits, tremor and 
loss of vibration sensation.  In this study 35 painters were assessed together 
with 42  community controls.  Neuropsychological tests included Trail Making 
Tests A & B, Benton Visual Retention Test, Continuous Performance Test and 
Symbol Digit Substitution Test, Associate Learning Test and Delayed Associate 
Recall.  All participants showed cognitive and neurological impairments on the 
above assessment instruments (Dick et al., 2000). 
 
Such changes have been related to supra modal learning impairments and 
recall deficits.  Other changes demonstrated have included; motor in-
coordination, cognitive inflexibility, poor verbal fluency and verbal memory, 
lowered manual dexterity, and numbness and weakness of the extremities 
(Haut et al., 1999; Dick et al., 2000). 
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Lezak states that specific cognitive deficits among individuals exposed to 
neurotoxins have been found on tests involving processing speed, co-
ordination, concentration, memory and vocabulary (Lezak 1995 & 2004). 
 
Morrow, Robin et al documented specific deficits in both forward and reversed 
digit span and in the acquisition of new information.  Their findings suggested 
that the amount of material that the individuals exposed to neurotoxins were 
capable of processing, was significantly reduced (Morrow, Robin et al., 1992). 
 
Not all studies have found neuropsychological dysfunction among solvent 
exposed workers.  A study of solvent exposed South African paint workers by 
Myers et al failed to show neuropsychological deficits in 228 solvent exposed 
workers.  However,  these researchers did consider in their conclusions that the 
tests they used were perhaps not particularly sensitive to subtle 
neuropsychological changes, nor were some of them appropriate for the mostly 
illiterate paint workers (Myers et al., 1999). 
 
Although an early study by Fiedler et al with 11 patients with multiple chemical 
sensitivity due to low level exposure to neurotoxins demonstrated 
neuropsychological test findings suggestive of CNS involvement, they later 
questioned such findings.  In a later study, Fiedler et al found that the 
prevalence of an  AXIS I  Psychiatric Diagnosis was greater in both multiple 
chemical sensitivity patients and those with chronic fatigue,  than in controls.  
They concluded that neuropsychological test results did not substantiate 
reported cognitive impairments.  However a final comment was made regarding  
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the lack of sensitivity of the neuropsychological tests used in their research 
(Fiedler et al., 1992; Fiedler et al., 1996). 
 
Reasoning and problem solving abilities may also be impaired in neurotoxically 
exposed workers, as well as visuo-spatial functions.  Executive functioning 
disorders have been demonstrated, and may present as reduced spontaneity, 
mental inflexibility, impaired planning ability and situation dependency (Haut et 
al., 1999). 
 
Emotional disturbances are often evident among chronically chemically 
exposed workers and can present as somatic preoccupations, depressive 
tendencies, anxiety and social withdrawal.  A study by Morrow et al investigated 
psychiatric symptoms among workers exposed to organic solvents.  In this 
study, 30 solvent exposed adults were evaluated via the Symptom Checklist - 
90-R, (SCL-R), the profile of Mood Scales (POMS) and the Beck Depression 
Inventory (BDI).  These 30 workers were compared to 30 normal controls.  All 
three measures demonstrated statistically significant differences between the 
chemically exposed workers and the controls (Morrow et al., 1993). 
 
Differences between the effects of particular solvents and how individuals are 
affected by them are the result of interactions between many variables.  These 
include; duration; intensity of exposure; age; physical status; emotional state; 
rate of metabolism; and the particular variety of neurotoxin involved (Morrow et 
al., 1993: Lezak, 1995 & 2004; White & Proctor 1997; Costa & Manzo, 1998). 
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1.3  The Current Situation in Workplaces 
There are many occupations in which workers are exposed to toxic chemicals 
which can cause health problems.  Some of these chemicals have been found 
to have a detrimental effect on the human brain and as a result can cause 
neuropsychological dysfunction.  These chemicals are known as neurotoxins 
because they are able to pass through the blood brain barrier and affect the 
functions of the brain. 
 
There are many chemical compounds present in a variety of work settings 
which can produce a range of impairments in the human nervous system.  The 
condition which arises from exposure to such compounds is known as 
neurotoxicity.  Neurotoxic substances may be chemically manufactured, such 
as Glutaraldehyde, or they may be naturally occurring, such as lead or uranium. 
 
Neurotoxic impairments among exposed workers can range from subtle 
neurological and behavioural disturbances, to more severe encephalopathy and 
peripheral nerve disease (Costa & Manzo, 1998; Baker, 1994; Edling et al., 
1990; Hartman, 1995; Nilson, Bärregard & Bächman, 1996; Spencer & 
Schaunburg, 2000; Lezak, 1995 & 2004). 
 
There can be subtle changes in brain function following neurotoxic exposure, 
such as concentration and memory difficulties, confusion, and language 
dysfluency.  However these symptoms are sometimes put down to “feeling 
unwell”, suffering “flu type” infections, or just “having a bad day” and are often 
ignored.  However with sustained exposure to neurotoxic chemicals, especially  
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where few or no protective measures are put in place, serious health problems, 
such as encephalopathy may develop.  In serious conditions such as these, 
brain function deteriorates significantly and physical or pathological changes 
can also be observed among the most severely exposed workers. 
 
Although the toxic effects of certain chemicals and minerals on the human body 
and central nervous system have been documented for centuries, it has only 
been since the 1970's that occupational neurotoxicity has emerged as a 
specialized area of study.  This is due to the more frequent use of chemicals in 
industrial, mining, aviation, agricultural and medical settings (Singer, 1990). 
 
The number of situations in which neurotoxicity has been recognized in 
exposed workers has also grown significantly over the past 25 to 30 years 
(Costa & Manzo, 1998; Spencer & Schaunburg, 2000). 
 
According to Costa & Manzo, (1998), 30% of the workplace chemicals, for 
which the American Conference of Governmental Industrial Hygienists have 
recommended maximum exposure concentrations, have been so listed in part 
because of their neurotoxic potential.  Many other chemicals also have 
neurotoxic properties, but they have not as yet been recognised. 
 
Toxic chemicals can be divided into five general groups. 
These are:- 
  Solvents and Related Organics 
  Pesticides 
  Metals and Metalloids  
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  Gases 
  Miscellaneous compounds (these may include formaldehyde, 
Glutaraldehyde and naphthalene). 
 
The above groups of compounds can be toxic to either the central nervous 
system, the peripheral nervous system or both.  Their mode of action is 
generally multifactorial and the effects are not necessarily predictably reversible 
(Spencer & Schaunburg, 2000). 
 
A report on multiple chemical sensitivity (MCS) by the Interagency Workgroup 
on MCS in 1998 stated: 
“The scientific literature is currently inadequate to enable determination of the 
associations between human exposure(s) to chemicals in the development or 
exacerbation of MCS.  Targeted research would reduce this uncertainty.   
Increased scientific knowledge about MCS and the role of environmental 
chemicals will inevitably be put into context of benefits and risk.  Virtually all 
chemicals in use convey both benefits and risks.  Every technology, no matter 
how beneficial, can exert a negative impact on some sector(s) of society.  Many 
chemicals have well established toxicologic and allergenic properties; 
undoubtedly, others will be found to have adverse effects in the future.  Public 
health leaders and other risk managers have an obligation to ensure that the 
benefits of technologies justify the risks.  The public health vision is health for 
the entire population.  The reality of public health will always involve balancing 
maximum benefit and minimum harm to the public‟s health and well-being”.  
(IWMCS August 1998). 
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The occupations which are at risk due to neurotoxic exposure are listed below 
in Table III 
TABLE  III 
 
Occupations at Risk  Neurotoxic Substances 
 
Agriculture and farm workers  Pesticides, herbicides, insecticides, 
  solvents 
Chemical and pharmaceutical workers  Industrial and pharmaceutical substances 
Degreasers  Trichloroethylene 
Dentists and dental hygienists  Mercury, aesthetic gases, Glutaraldehyde 
Dry cleaners  perchloroethylene, trichloroethylene other 
  solvents 
Electronic workers  Lead, methyl ethyl ketone, methylene 
  chloride, tin, trichloroethylene, glycol ether, 
  xylene, chloroform, Freon, arsine 
Hospital personnel  Alcohols, anaesthetic gases, ethylene 
  oxide and Glutaraldehyde (cold sterilization) 
Laboratory workers  Solvents, mercury, ethylene oxide, 
  Glutaraldehyde 
Painters  Lead, toluene, xylene, other solvents 
Plastic workers  Formaldehyde, styrene, PVC‟s 
Printers  Lead, methanol, methylene chloride, 
  toluene, trichloroethylene, other solvents 
Rayon workers  Carbon disulfide 
Steel workers  Lead, other metals, phenol 
Transportation workers  Lead (in gasoline), carbon monoxide, 
  solvents 
Hobbyists  Lead, Toluene, glues, solvents 
Office workers  Solvents 
    (Hartman, 1995) 
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In evaluating individuals exposed to toxins it is important to take into account 
the nature of the exposure.  High level acute exposure is typically a one time 
event, occurring as an accidental release of toxic substances.  Although long-
term chronic exposure to lower levels of toxins may not have the observable 
effects of the single acute exposure, the cumulative effects of the toxin may 
nevertheless result in neurotoxic disorders over time (Baker, 1994, Lezak, 1995 
& 2004). 
 
Over the past decade or two, the issue of low level chemical exposures and the 
effects that such exposures may cause, has received considerable attention.  
While conventional toxicological concepts can explain the effects of high toxic 
exposures, the issue of effects from low level chemical exposure is a relatively 
new area of study (Winder & Balouet, 2001). 
 
A study of workers with very low level exposures has demonstrated only mild 
deficits on attentional tasks requiring mental shifting and response speed, but 
no memory deficits or distress symptoms.  However, low level exposure to 
chemicals which are used as nail treatments in beauty salons, has been 
associated with mild cognitive inefficiencies (Lezak, 2004). 
 
Neurotoxic symptoms may differ greatly with variations in the degree and 
duration of exposure.  Some neurotoxic effects may take time to evolve, and it 
may be decades after the exposure before the effects are clearly evident.  
There is also evidence to suggest that extremely low levels of pollutants that are 
insufficient to produce neurological symptoms, may predispose susceptible  
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individuals to the later development of a progressive nervous system disorder 
(Costa & Manzo, 1998; Nilson et al., 2002). 
 
Table IV below, illustrates a variety of neurological effects which have been 
observed following exposure to various chemicals in the workplace. 
 
TABLE  IV 
The Neurological Effects of some Commonly Used Neurotoxins 
Chemical  Effect 
  Solvents 
Carbon disulfide  mild peripheral neuropathy, cranial neuropathy, 
  ataxia, impairment of psychomotor function, 
  Parkinson's Syndrome Psychosis, emotional 
  instability, memory impairment 
Methanol  impaired visual acuity, blindness, headache 
Perchloroethylene  Encephalopathy, impaired psychomotor function, 
  neurasthenia 
Styrene  Neurobehavioural and neuroendocrine alterations 
Toluene  Ataxia, emotional lability 
Trichloroethylene  Cranial neuropathy, memory impairment 
  Pesticides 
Chlorophenoxy compounds  Headache, dizziness, myotonia, neuropathy 
  fatigue 
Cyclodienes (chlordane, aldrin)  Ataxia, seizures, EEG pattern changes, chronic 
  Motor disorders, psychological disorders 
Dithiocarbamates  Muscle weakness, dizziness, inco-ordination  
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Organophosphates  Acute cholinergic crisis, central and 
  Autonomic NS toxicity, cranial nerve palsies, 
  delayed peripheral neuropathy, spasticity, 
  impaired psychomotor function 
Pyrethroids  Tremor, choreoathetosis 
  (Costa & Manzo, 1998) 
  Gases 
Carbon monoxide  Encephalopathy, delayed syndrome, dystonia 
Ethylene oxide  Headache, neuropathy, seizures 
Cyanide  Ataxic neuropathy, visual disturbances (chronic) 
Hydrogen sulphide  Encephalopathy 
Methyl bromide  Visual and speech impairment, convulsions 
  (acute); neuropathy, cerebellar symptoms 
  (chronic) 
Methyl chloride  Cerebellar dysfunction, ataxia, tremor, blurred 
  vision, loss of recent memory 
Nitrous oxide  Neuropathy 
Waste anaesthetic gases  Headache, memory impairment 
  Metals 
Aluminium  Encephalopathy 
Arsenic  Mixed sensori-motor neuropathy, 
  encephalopathy 
Lead  Motor neuropathy, memory impairment, 
  Impaired psychomotor function, neurasthenia 
Manganese  Ataxia, Parkinsonism, dystonia, cognitive  
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  impairment, emotional instability, psychosis 
Mercury  Tremor, fatigue, emotional disturbances, 
  neurasthenia, cognitive impairment 
  (elemental Hg) 
Thallium  Peripheral and autonomic neuropathy, ataxia, 
  Emotional disturbances, psychosis 
  Miscellaneous 
Acrylamide  Sensori-motor neuropathy, ataxia, neurasthenia 
Methyl methacrylate  Sensori-motor neuropathy 
Naphthalene  Neuropathy, optic neuritis 
  (Costa & Manzo, 1998) 
 
In Australia, on the basis that there were seen to be reasonable grounds for 
believing that the production, handling, use and disposal of industrial chemicals 
could give rise to a risk of adverse health effects, the Industrial Chemicals 
(Notification and Assessment) Act of 1989 was passed, (NICNAS, 1989).  The 
object of the Act was to provide a national system of notification and 
assessment of industrial chemicals for the purpose of:- 
(a)  Aiding in the protection of the Australian people and the environment, by 
determining the risks to Occupational Health and Safety; Public Health; 
and the environment; that could be associated with the importation, 
manufacture or use of the chemicals; and 
(b)  Providing information and making recommendations, about the 
chemicals to Commonwealth, State and Territory bodies with 
responsibilities for the regulation of industrial chemicals; and  
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(c)  Giving effect to Australia's obligation under international agreements 
relating to the regulation of chemicals; and 
(d)  Collecting statistics in relation to chemicals; being a system under which 
information about the properties and effects of the chemicals is obtained 
from importers and manufacturers of the chemicals (NICNAS, 1989). 
 
The Industrial Chemicals (Notification and Assessment) Act (1989) was 
subsequently amended in 1997 to broaden its focus and this resulted in The 
Industrial Chemicals (Notification and Assessment) Amendment Act of 1997. 
 
Worksafe Australia, in its February 1995 Newsletter, outlined grave concerns 
regarding the dangers of chemical exposure in workplaces in Australia.  
Worksafe estimated that there are annually 2,200 occupational deaths in 
Australia, which are chemically related.  This is 80% of the total workplace 
deaths occurring annually. 
 
The Australian Plaintiff Lawyers Association (APLA), (now the Australian 
Lawyers Alliance), has established a special interest group to investigate 
chemical injury cases, with a long term view of initiating legislative change in 
this area.  The APLA Conference in 1998 included three papers on chemical 
injury; two by psychologists, and one by a medical practitioner (Shores & 
Simpson, 1998; Coxon, 1998; Donohoe, 1998).  
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Changes to Health and Safety Legislation can only be enacted when there is 
significant evidence that exposure to certain chemicals results in health risks to 
workers.  For example, the chemical Glutaraldehyde (CAS No, 111-3008) was 
declared by the Commonwealth Minister for Industrial Relations as a priority 
existing chemical (PEC) under the Industrial Chemicals (Notification and 
Assessment) Act 1989 (Commonwealth), (the Act), by notice in the Chemical 
Gazette of 2
nd March 1993. 
 
The declaration was made on the basis that there were reasonable grounds for 
believing that the production, handling, use and disposal of Glutaraldehyde 
could give rise to a risk of adverse health effects.  (NICNAS, 1997). 
The most recent Safety Information Sheet released in October 2000, states. 
A product containing more than 0.1% Glutaraldehyde is classed as a 
Hazardous Substance.  Glutaraldehyde is not classified under the Australian 
Dangerous Goods Code.  However, solutions of more than 25% Glutaraldehyde 
are corrosive and would fit onto Class 8 of the Code.  Lower concentrations 
meet the classification for 6.1 (b) substances.  (NICNAS Website: 2009 
www.nicnas.gov.au)  
 
Priority Existing Chemicals (PECs) are existing chemicals which have been 
assessed on a priority basis in response to concerns about their health or 
environmental effects or both. 
 
These chemicals undergo a six step review process in order to be classified as 
PECs.  
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These steps are: 
Step  1  Nomination 
Any person or organization with concerns about the public health, occupational 
health and safety or environmental effects of an industrial chemical, may 
nominate it for assessment. 
Step  2  Screening and Information Gathering 
Once nominated, chemicals are screened to determine if they are eligible for 
inclusion in the program. 
Step  3  Declaration 
The Director uses the information that is obtained through the screening and 
ranking process, together with any information from a Section 48 Notice to help 
decide whether to recommend to the Minister for Health and Ageing, that a 
chemical be declared as a PEC. 
Step  4  Assessment 
Once a chemical has been declared a PEC all importers and manufacturers are 
required to make an application for assessment within 28 days of the 
declaration.  A “Weight of Evidence” approach is adopted in the assessment of 
each chemical, taking into account all available information including published 
literature, unpublished data, public information, international assessments and 
the data submitted in response to Notices placed in the Chemical Gazette. 
Step  5  Public Comment 
NICNAS is committed to industry and public involvement and sees consultation 
with these groups as an essential part of the assessment process.  
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Step  6  Outcomes 
Through the assessment reports; information on any risks to human health and 
the environment and recommendations on ways to control and reduce any risks 
is made available to companies introducing chemicals to people within the 




1.4  Outline of the Problem 
Due to the above mentioned range of health problems which can develop 
following exposure to neurotoxic substances, it is considered very important that 
an awareness of the early stages of neurotoxicity be recognized.  This would 
ensure that measures can be put into place to prevent the insidious 
deterioration in brain function of exposed individuals, which could eventually 
become permanent in nature over time. 
 
Workers can be exposed to neurotoxins via a number of routes, such as direct 
skin contact and absorption through the skin; via inhalation into the respiratory 
system; and also via ingestion into the alimentary tract.  In agricultural settings 
there may be widespread use of neurotoxic sprays in the form of herbicides or 
pesticides, which infiltrate whole areas of the atmosphere and environment.  In 
such situations, the wind factors involved may increase the exposures of these 
chemicals to individuals other than the workers themselves such as members of 
the public, children in nearby rural schools, and workers in other neighbouring 
areas.  
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In aviation settings where workers are situated in closed environments, such as 
aircraft cockpits and cabins, they are more vulnerable, as they are very 
dependent on adequately functioning air conditioning systems to supply vital 
supplies of oxygen.  Should neurotoxic materials be leaked via their ventilation 
systems, into enclosed spaces, such as cockpits and galleys where pilots and 
flight crew are situated, the outcome can be serious.  There have been reported 
incidents where pilots have been exposed to jet oil emissions via leaks in air 
conditioning seals, which have caused intoxication of both pilot and co-pilot, to 
the extent that a loss of consciousness was experienced (Winder et al., 2000; 
Winder, 2005, 2006; Coxon, 2002, 2005, 2006; Loraine, 2007; Michaelis, 2007, 
2008). 
 
Another factor which may interact with potential neurotoxic impacts is hypoxia, 
which may occur in pressurized aircraft cabins as postulated by Winder in his 
case study on hazardous chemicals on jet aircraft  (Winder, 2006). 
 
In another aviation setting an alarming situation has arisen in Australia over the 
past 25 years among RAAF aircraft maintenance engineers who have been 
exposed to jet fuels and toxic sealants as part of the F-III Deseal/Reseal 
Project.  This project took place over a 25 year period from early 1975 to late 
1999 (RAAF/ADF 2004). 
 
Approximately 700 RAAF aircraft maintenance workers were involved in the 
Deseal/Reseal Program over a 25 year period, which resulted in significant 
health problems, which included;  cardiovascular problems, respiratory tract  
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difficulties,  neurological and neuropsychological deficits and mental health 
problems.  When these health problems were identified, the program was 
terminated.  The RAAF accepted liability and conducted a wide scale 
assessment of the health effects of the workers involved in the program.  This 
wide scale health study resulted in the publication of “Study of Health Outcomes 
in Aircraft Maintenance Personnel” (SHOAMP,  September 2004). 
 
Not only were these RAAF workers adversely affected by their exposure to the 
toxic chemicals in their workplace, but also their spouses were indirectly 
affected in a number of ways (Coxon, Hartley et al., 2006). 
 
The RAAF were so concerned about the impact of the chronic illnesses of the 
maintenance engineers involved in the Deseal/Reseal Program on their 
spouses, that a study was commissioned to investigate this impact, (Coxon, 
Hartley, et al., 2006) which took place in 2005 and 2006. 
 
Another area, where only limited research has been carried out to date, is in the 
hospital setting, where many health care workers, such as nurses, x-ray 
assistants and radiographers are exposed to neurotoxic substances in the 
course of their work (SNFTAAS, 1999).  With the HIV and AIDS “epidemic” of 
the early 1980‟s, stronger and stronger chemicals were required to destroy the 
viruses responsible for these conditions.  Hence potent chemical agents were 
introduced for the sterilisation of instruments, in order to prevent cross infection 
from one patient to another in operating theatres. 
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With the advent of “key hole” surgery in recent years, to reduce the 
intrusiveness of “open surgery”, very fine fibre optic endoscopes were 
introduced.  These instruments, which were very delicate, could not be sterilized 
using traditional heat based autoclaves, as the high temperatures would have 
destroyed the delicate fibres.  Consequently potent cold sterilization agents, 
such as Glutaraldehyde were required to effectively destroy bacteria and also 
dangerous viruses, such as HIV, which were prevalent at the time. 
The major sterilization agent which was introduced in the early 1980‟s for this 
purpose, was the chemical Glutaraldehyde.  Glutaraldehyde is a colourless fluid 
which is manufactured with a variety of concentrations from 50% downwards, to 
be later diluted into 2-3% and 1% solutions.  With its initial use in the early 
1980‟s, stronger 2-3% solutions were used, as speed of sterilization was 
essential, due to the cost of the endoscopes and the limited supply of these 
delicate instruments.  As a rapid “turn around” period was required, due to the 
scarcity of endoscopes, individuals working in these sterilization units 
considered that stronger solutions would sterilize these instruments more 
rapidly and effectively, and thus valuable time would be saved. 
 
Unfortunately due to this “time poor” situation, shortcuts were taken with the 
protective measures used.  Nursing staff and other health care workers claimed 
that they did not have sufficient time to don gloves, aprons and respirators, 
which would have provided protection from chemical skin splashes and 
inhalation of fumes emanating from the Glutaraldehyde containers (Coxon, 
1998).  Warnings regarding the hazards associated with the use of 
Glutaraldehyde, appear to have been unheeded for quite some time, until  
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complaints of sickness among many health care workers began to be 
documented (Vyas, 1997; Clifford, 2003). 
 
Vyas undertook a rigorous Glutaraldehyde study where 358 endoscopy nurses 
in 59 units were investigated for symptoms related to Glutaraldehyde exposure.  
Seventy percent of the nurses had respiratory tract symptoms, and nasal and 
lower respiratory tract symptoms were most common of these (Vyas 1997). 
 
Gradually more and more health care workers began complaining of health 
problems such as; coughs, breathing difficulties, skin rashes on faces and 
hands and chronic headaches.  However, after periods of time away from their 
workplaces these workers were thought to have “recovered”, as their symptoms 
reduced significantly. 
 
However, with time, more concerning problems began to emerge as these early 
workers in the health care industry were being exposed more frequently and 
more intensively to Glutaraldehyde.  They began complaining of cognitive 
problems, which included; concentration and memory difficulties, slowed motor 
speed, slowed reaction time to stimuli, feelings of “vagueness” and episodes of 
confusion. 
 
A brief neuropsychological study was carried out in the 1990‟s by researchers in 
New Zealand, where the problem of Glutaraldehyde exposure was considered 
to be of significant concern, as a radiographer had died after prolonged 
exposure to Glutaraldehyde (Clifford, 2003).  This small scale study was  
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conducted by noted New Zealand Neuropsychologist, Professor Dorothy 
Gronwall, who demonstrated significant neuropsychological impairments in 
health care workers  who were exposed to Glutaraldehyde in the course of their 
work.  Their deficits included; poor visuo-spatial perception, impairments in non 
verbal memory, lowered attention and concentration, slowed information 
processing speed, verbal fluency problems, slow reaction times and impaired 
executive functioning.  However the numbers in the study were small and there 
was no control group for comparison (Gronwall, 1997).  
 
Another psychologist in Australia, Richard Teo, used an electro-encephalograph 
study, via Auditory Event Related Potential, P300 recordings, involving nurses 
exposed to Glutaraldehyde in the 1980‟s and 1990‟s, with some significant 
findings.  Teo & Naidu considered that their data of P300 recordings 
demonstrated a degree of brain dysfunction in a population of nurses who 
worked with Glutaraldehyde.  However the numbers were small and no control 
group for comparison was used (Teo & Naidu, 1994).  
  
According to Cognitive Neuroscientists, Ullsperger & Mecklinger, the P300 
component of the Event Related Potential Recording reflects integrative 
information processing of the brain that is often described as “endogenous”.  
(Ullsperger & Mecklinger, 1996). 
 
In order to support the hypothesis that health care workers exposed repeatedly 
to the chemical Glutaraldehyde would suffer cognitive dysfunction, this present 
study was undertaken.  
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A preliminary investigation was conducted by Coxon with four health care 
workers exposed to Glutaraldehyde, where only minimal protective measures 
were in place.  The four workers were assessed neuropsychologically, via a 
battery of well known neuropsychological tests, including;  WAIS-III, WMS-III and 
components of the Halstead Reitan Battery,  which were considered to be 
sensitive to neurotoxic substances.  This initial study suggested that there were a 
number of areas of brain dysfunction which could be found in individuals who 
were exposed to Glutaraldehyde on a long term basis.  It was concluded that the 
areas of brain dysfunction following exposure to Glutaraldehyde were likely to 
include;  speed of information processing; reaction time to stimuli; memory and 
concentration; and fine motor skills.  It was then considered that further and more 
extensive investigations were required to replicate these findings with a larger 
group of participants,  including a control group (Coxon, 1998). 
 
As a consequence it was decided that a study would be conducted to investigate 
further the deleterious effects of Glutaraldehyde on health care workers, in terms 
of their cognitive functioning and emotional state.  Assessments would include; 
processing speed, reaction time to stimuli, memory and concentration skills and 
measures of anxiety and depression.  If the outcome proved positive,  this 
evidence could well lead to more stringent safety measures being introduced in 
many workplaces where the chemical Glutaraldehyde is used. This would 
hopefully prevent adverse health problems from recurring in such work settings.  
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CHAPTER  2 
Aims 
2.1  The Aims of the Projects 
The aims of the three research projects were: 
(a)  To determine whether the subjective reports of cognitive confusion, 
cognitive dysfunction and emotional distress following occupational 
exposure to aircraft jet engine fuel emissions in the aviation industry could 
be validated. 
(b)  To investigate whether chronic health problems and neuropsychological 
dysfunction suffered by RAAF maintenance engineers exposed to toxic 
chemicals as part of the F-III Deseal/Reseal program, would have impacted 
on the emotional state and coping capacity of their spouses. 
(c)  To determine if the subjective reports of cognitive confusion,  cognitive 
dysfunction, neurological problems and emotional distress following 
exposure to Glutaraldehyde in hospital settings could be validated. 
 
The above aims are proposed to be achieved by administering a range of 
psychometric tests, considered to be sensitive to chemical injuries, to a group of 
flight crew exposed to jet oil emissions of the BAe-146 aircraft; to administer 
burden of care and sensitive clinical inventories to the spouses of chemically 
exposed aircraft engineers; and to administer the above mentioned 
psychometric tests to two groups of health care workers, exposed to the 
chemical Glutaraldehyde in hospitals and clinics.   
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The research hypotheses of these studies are three fold: 
1)  Toxic jet oil emissions from faulty BAe-146 aircraft will affect the 
cognitive functioning of pilots and flight crew. 
2)  The burden of caring for chronically affected workers exposed to toxins in 
the RAAF F-III Deseal/Reseal program will impact significantly on the 
mental health and coping skills of their spouses. 
3)  Occupational exposure of health care workers to the chemical 
Glutaraldehyde, will result in cognitive dysfunction and emotional 
distress.  
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CHAPTER  3 
BAe-146 Aircraft Study 
3.1  Neurotoxicity Problems in Aviation Settings 
The following is an extended version of an article published in the Journal of 
Occupational Health and Safety, Australia and New Zealand  Volume 18 pp 
313-319  2002 entitled “Neuropsychological Assessment of a Group of BAe-146 
Aircraft Crew Members Exposed to Jet Engine Oil Emissions.” 
 
Over the past 10 or more years, reports have been made by airline pilots, cabin 
crew and passengers, outlining an array of symptoms arising from travel on 
BAe-146 aircraft.  The BAe-146 is a small jet aircraft that operates on short 
domestic flights within Australia, Britain, Canada, Alaska and Sweden.  In 
Australia, the BAe-146 is used predominantly in the less populated states of 
Western Australia, Queensland and South Australia, as a means of transporting 
small numbers of passengers to the more remote areas (Winder, 2001 & 2005; 
Coxon, 2002 & 2005; Mackenzie-Ross, 2005, 2006; Michaelis, 2007 & 2008; 
Loraine, 2007). 
 
The most common complaints which have been made by individuals exposed to 
engine oil emissions while flying on the BAe-146 aircraft are; breathing 
difficulties; chest pain; nausea; fatigue; chronic headaches; dizziness; light 
headedness; confusion; concentration problems; memory difficulties and 
hypersensitivity to a range of chemicals (Winder & Balouet, 2001; Coxon, 2002 
& 2005; Winder, 2005).  
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Complaints are generally made when the crew and passengers are exposed to 
jet oil emissions through the air conditioning system of the aircraft, often during 
take off and landing. 
 
The oil escapes through faulty oil seals and into the compressor bleed air, 
which is used to ventilate and pressurise the BAe-146 aircraft cabins (Tyrrell, 
1999).  The concentration of these emissions is considered to peak at take off 
and landing of the planes, or at other times when the engine is under load.  
Reports of foul smelling gases and the subsequent development of symptoms 
of nausea, breathing difficulties, chest pain, confusion and dizziness are most 
common among flight crew at times when the air conditioning systems are on 
full volume. 
 
The jet oil used by the BAe-146 aircraft is a synthetic phosphate ester oil in 
which tricresol phosphates are constituents.  One of these tricresyl phosphates, 
tri-ortho-cresyl phosphate (TOCP), is said to be a highly neurotoxic contaminant 
(Donohoe, 1998).  However, other ortho-cresyl phosphates in the oil are present 
in higher concentrations and are known to be even more neurotoxic than TOCP 
(Winder & Balouet, 2001; Winder, 2006). 
 
This oil also contains naphthalene and a broad range of other chemicals, many 
of which are considered hazardous to human health (Donohoe, 1998; Winder & 
Balouet, 2001). 
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On the International scene, the BAe-146, the MD80, the B737 and the A300 
aircraft have been the cause of over 90% of the world wide cabin contamination 
problems identified.  It is considered that this is due to the fact that the above 
mentioned aircraft are more prone to leakages of oil emissions, due to their 
particular design.  The BAe-146 engine was reported to have been designed for 
use in combat helicopters during the Vietnam War.  Post war these engines 
have been modified to fit into small jet aircraft operating on short domestic 
flights.  Statistically, the BAe-146 aircraft operating in Australia, Canada, Alaska 
and Sweden are the highest ranking for all cabin air problems (Winder & 
Balouet, 2001; Loraine, 2007). 
 
Several case reports and epidemiological studies suggest that chronic Central 
Nervous System effects may occur in solvent-exposed workers, such as 
workers exposed to jet engine oils.  Headaches, dizziness, concentration 
difficulties, memory impairment, fatigue, irritability, depression, alcohol 
intolerance and personality changes are the most frequently reported 
symptoms.  Psychometric testing has revealed disturbances in memory and 
perception, also prolonged reaction times and some loss of coordination (Costa 
& Manzo, 1988). 
 
Hartman cites studies demonstrating acute neurophysiological effects on jet oil 
workers, which include; dizziness, headaches and fatigue.  Chronic exposure 
produces symptoms of neurasthenia, anxiety, depression and increased 
reaction time to stimuli.  Of the most severely affected in this study, 50% were 
considered to have mild organic brain syndrome (Hartman, 1995).  
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Flight safety is a major issue, when one considers the effects on crew who are 
exposed to jet engine oil emissions as described above (Winder et al., 2001).  A 
pilot with disorientation, altered memory, concentration difficulties, blurred vision, 
slurred speech, and loss of balance and co-ordination could not be expected to 
operate and land an aeroplane safely, nor could cabin crew be expected to carry 
out their duties adequately when experiencing the above mentioned problems. 
 
Despite numerous complaints of cognitive problems following exposure to BAe-
146 jet oil emissions, very few psychometric assessments have been conducted 
to determine the nature and magnitude of the reported problems. 
 
However, one study by Teo in 1999,  in which he assessed five airline crew, 
including two pilots and three flight attendants, exposed to jet oil emissions, 
significant findings were demonstrated.  Teo assessed each of the five 
individuals using Auditory Evoked Response Potentials (AERP).  He reported 
that the AERP test is a useful tool for the detection of chemical exposure 
effects, as it can detect the depressant effects of organo-phosphates and other 
chemicals, even at sub clinical levels.  He said that the resultant effects of 
organo-phosphate and solvent exposure are that the ability of individuals to 
attend and respond to stimuli is decreased (Teo, 1999).   
 
The results of Teo's 1999 study revealed that in each case, there was a 
significant deficit in the individual's capacity to process information efficiently.  
This dysfunction impacted on the individuals' performances on cognitive and  
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psychomotor tasks.  This was considered by Teo to be an air safety risk factor 
(Teo, 1999). 
 
Despite the above mentioned AERP findings, there do not appear to be any 
comprehensive neuropsychological studies carried out in Australia on groups of 
individuals exposed to jet engine oil emissions. 
 
According to Lezak, the lack of thorough investigation of reported cognitive 
problems among chemically exposed workers generally occurs because of the 
similarity between some of the reported complaints and those of both 
depression and neuroticism.  This confusion, often coupled with the absence of 
distinct neurological symptoms, can lead naïve investigators into discounting 
chemically exposed workers' complaints of cognitive deficits as being of no real 
concern (Lezak, 1995). 
 
However, Lezak reported that when neuropsychological evidence is presented, 
individuals' symptoms are often supported by positive objective findings.  The 
most prominent of these cognitive deficits involve many aspects of attention and 
memory and also response time slowing (Lezak, 1995). 
 
The health problems of cabin staff exposed to BAe-146 jet oil emissions were 
considered to be of such significant concern as to warrant an inquiry by the 
Australian Senate.  The Journal of the Senate, No 24, dated 22 March 1999 
stated that; “the following matter be referred to the Rural and Regional Affairs 
and Transport References Committee for Inquiry and Report.  This matter was;   
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“(d)  The examination of air safety, with particular reference to cabin air quality 
in BAe-146 aircraft". 
 
Six senators, representing five states of Australia, subsequently met in 1999 
and 2000 to investigate the 24 public submissions and a number of other 
private submissions on air quality in the BAe-146 aircraft.  A report was tabled 
in the Australian Parliament in October 2000 (Senate Rural and Regional Affairs 
and Transport References Committee October 2000). 
 
3.2  BAe-146 Study in Western Australia 
The aim of this study was to determine the presence of any neuropsychological 
deficits among a small group of airline pilots and flight crew exposed to jet 
engine oil emissions from the BAe-146 aircraft, in the course of their work. 
 
3.3  Participants 
A medical practitioner, based in Perth, Western Australia, who treated many of 
the flight crew affected by BAe-146 emissions, considered that 
neuropsychological assessment was necessary in order to determine the nature 
and extent of the problems which were being reported.  She therefore referred 
five flight attendants for neuropsychological assessment.  Another flight 
attendant and two pilots were referred by their own medical practitioners from 
the other states of Australia (Somers, 2005). 
 
In total, eight air crew exposed to BAe-146 oil emissions were referred by their 
medical practitioners for neuropsychological assessment.  These individuals  
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reported cognitive difficulties, such as; mental confusion, concentration 
difficulties and memory problems,  following their exposure to jet oil emissions. 
 
The eight individuals assessed were all females.  Six were cabin crew members 
and two were pilots.  Their ages ranged from 24 to 56 years and they had 
worked in their respective positions on the BAe-146 aircraft from two years to 
twelve years.  All had completed twelve years of secondary school education 
and most had studied at a tertiary level.  All participants were right hand 
dominant. 
Mean age of participants was 36.13 years and mean education in years was 
13.67 years. 
 
3.4  Measures 
Each of the eight participants was administered a battery of neuropsychological 
tests, which had been used in previous research studies on neurotoxicants 
(Coxon, 1999; Miller, 1996, 1999; Worth et al., 1993; Crowe & Casey, 1999; 
Gronwall, 1997).  
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The Test Battery:  
  WAIS-III Subtests 
  Wechsler Memory Scale - Russell Adaptation 
  Rey Complex Figure 
  Controlled Oral Word Association Test (FAS Test) 
  Symbol Digit Modalities Test 
  Trail Making Tests "A" and "B" 
  Card Version of Category Test 
  Rey 15 Item Test 
  Dynamometer Grip Test 
  Reitan Finger Tapping Test 
  Grooved Pegboard Test 
  National Adult Reading Test 
  California Computerized Assessment Package (CALCAP) 
 
The Californian Computer Assessment Package (CALCAP) designed by Dr Eric 
Miller was added to the test battery as it is regarded as a sensitive measure of 
subtle changes in cognitive functioning among a number of populations, such 
as HIV positive individuals; chronic fatigue syndrome sufferers; and those with 
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3.5  Results 
 
TABLE  V    Summary of Test Scores 
  Age  Educ  FIQ  VIQ  PIQ  Inf  D Span  Vocab  Arith  Comp  Sim  LNS                                                             
                                                                                     
Mean  36.13  13.67  109.38  109.50  107.75  12.38  9.88  10.75  11.63  13.50  9.88  8.75                                                             
Std err  3.28  0.61  2.60  1.60  4.24  0.60  1.13  0.45  0.53  0.68  0.79  0.94                                                             
Std Dev  9.26  1.51  7.35  4.54  12.00  1.69  3.18  1.28  1.51  1.93  2.23  2.66                                                             
Samp Var  85.84  2.27  53.98  20.57  143.93  2.84  10.13  1.64  2.27  3.71  4.98  7.07                                                             
Kurtosis  3.44  -2.83  -0.56  -0.86  -0.03  -0.91  1.81  3.03  0.66  0.78  3.50  0.95                                                             
Skewness  1.40  -0.21  0.09  0.47  -0.57  0.17  0.68  -1.56  -0.15  -0.32  -1.64  -0.31                                                             
Range  32.00  3.00  22.00  13.00  35.00  5.00  11.00  4.00  5.00  6.00  7.00  9.00                                                             
Minimum  24.00  12.00  99.00  104.00  87.00  10.00  5.00  8.00  9.00  10.00  5.00  4.00                                                             
Maximum  56.00  15.00  121.00  117.00  122.00  15.00  16.00  12.00  14.00  16.00  12.00  13.00                                                             
Sum  289.00  82.00  875.00  876.00  862.00  99.00  79.00  86.00  93.00  108.00  79.00  70.00                                                             
Count  8.00  6.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00                                                             
                                                                                     
 
     
                                                                             
                                                                                     
  SS  Pict 
Comp 
Pict Arr  Block  MR  Dig Sym  NART  Grip D  Grip L 
ND 
Tap D  Tap ND                                                               
                                                                                     
Mean  9.50  13.50  9.38  11.75  12.63  7.38  18.38 
(FS Q 
113) 
24.06  25.03  48.99  46.03                                                               
Std err  0.87  1.09  0.82  0.86  0.91  0.75  1.44  1.60  1.24  3.36  2.04                                                               
Std Dev  2.45  3.07  2.33  2.43  2.56  2.13  4.07  4.52  3.50  9.49  5.76                                                               
Samp Var  6.00  9.43  5.41  5.93  6.55  4.55  16.55  20.44  12.22  90.11  33.18                                                               
Kurtosis  -0.51  0.44  -1.41  -1.02  0.25  -1.15  -1.86  -0.44  -1.26  -1.54  -1.32                                                               
Skewness  -0.47  -0.55  0.57  -0.33  -0.81  -0.53  0.37  -0.15  -0.19  0.17  0.41                                                               
Range  7.00  10.00  6.00  7.00  8.00  6.00  10.00  13.25  9.50  25.70  15.30                                                               
Minimum  6.00  8.00  7.00  8.00  8.00  4.00  14.00  16.75  20.00  36.30  40.00                                                               
Maximum  13.00  18.00  13.00  15.00  16.00  10.00  24.00  30.00  29.50  62.00  55.30                                                               
Sum  76.00  108.00  75.00  94.00  101.00  59.00  147.00  192.50  200.25  391.89  368.27                                                               
Count  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00                                                               
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TABLE  VI     Summary of Test Scores 
                                                                                       
  Pegs D  Pegs ND  Category   Rey 15 
item 
LM ST  LM LT  VR ST  VR LT  Rey copy  Rey 
Recall 
FAS                                                                 
                                                                                       
Mean  63.88  66.66  38.57  14.14  21.06  18.13  10.31  8.25  32.17  15.67  44.38                                                                 
Std err  4.01  6.19  6.61  0.55  0.90  0.99  0.64  1.00  1.01  1.56  5.61                                                                 
Std Dev  11.33  17.50  17.48  1.46  2.54  2.79  1.81  2.82  2.48  3.83  15.87                                                                 
Samp Var  128.41  306.14  305.62  2.14  6.46  7.77  3.28  7.93  6.17  14.67  251.98                                                                 
Kurtosis  -0.51  0.32  1.69  -0.84  -1.45  4.77  3.50  -1.20  -1.62  5.21  -0.24                                                                 
Skewness  0.54  1.09  -0.64  -1.23  0.24  2.07  -1.13  0.04  0.07  -2.25  0.44                                                                 
Range  33.00  49.00  57.00  3.00  7.00  8.50  6.50  8.00  6.00  10.00  48.00                                                                 
Minimum  49.00  51.00  7.00  12.00  18.00  16.00  6.50  4.50  29.00  8.00  21.00                                                                 
Maximum  82.00  100.00  64.00  15.00  25.00  24.50  13.00  12.50  35.00  18.00  69.00                                                                 
Sum  511.00  533.30  270.00  99.00  168.50  145.00  82.50  66.00  193.00  94.00  355.00                                                                 
Count  8.00  8.00  7.00  7.00  8.00  8.00  8.00  8.00  6.00  6.00  8.00                                                                 
                                                                                       
                                                                                       
                                                                                       
                                                                                       
                                                                                       
  SDMT W  SDMT O  Trails A  Trails B  SRT  RT  SEQRT  SEQRT2                                                                       
                                                                                       
Mean  43.88  49.00  37.88  76.38  -2.19  -3.91  -1.73  -0.93                                                                       
Std err  2.10  3.20  3.77  7.16  1.18  1.53  0.49  0.34                                                                       
Std Dev  5.94  9.04  10.67  20.25  3.35  4.34  1.39  0.97                                                                       
Samp Var  35.27  81.71  113.84  409.98  11.22  18.80  1.94  0.95                                                                       
Kurtosis  1.56  -0.80  -0.84  -1.24  0.80  1.28  -1.15  1.40                                                                       
Skewness  -1.20  -0.47  0.62  0.18  -1.29  -1.02  0.23  -0.03                                                                       
Range  19.00  25.00  30.00  56.00  9.26  13.29  4.00  3.37                                                                       
Minimum  32.00  34.00  25.00  50.00  -8.77  -12.49  -3.63  -2.62                                                                       
Maximum  51.00  59.00  55.00  106.00  0.49  0.80  0.37  0.75                                                                       
Sum  351.00  392.00  303.00  611.00  -17.52  -31.26  -13.85  -7.42                                                                       
Count  8.00  8.00  8.00  8.00  8.00  8.00  8.00  8.00                                                                       
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Surface examination of test results are shown in Table VII below 
 
TABLE  VII   Test Results 
Participants 

































































































































































































































































































































































































































































Impairments   -   * Mild   ** Mild to Moderate   *** Moderate   **** Moderate to Severe   ***** Severe 
 
 
These results indicate that the tests which demonstrated greatest sensitivity to 
neurotoxic exposure were the CALCAP Reaction Time tests.  Of the participants, 
87.5% demonstrated impairments in the choice and sequential reaction time 
tasks.  Interestingly, the simpler tests demonstrated the most severe impairments.  
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Surface examination of impairment levels are shown in Table VIII below 
TABLE   VIII   Impairment  Summary 
Impairment Levels 
 
Tests  Nil  Mild  Mild to 
Moderate 
Moderate  Moderate 
to Severe 
Severe  Total % of 
Participants 
Impaired 
Digit Symbol Test   1  4    2  1    87.5% 
Picture Arrangement Test  3  3  2        62.5% 
Digit Span Test   4  3    1      50% 
Letter Number Sequencing Test  4  2  1    1    50% 
SDMT Written  1  3  3  1      87.5% 
SDMT Oral  3  2    3      62.5% 
Trail Making Test "A"  5  2  1        37.5% 
Trail Making Test "B"  5  2  1        37.5% 
Grip Right   0  5  1  1  1    100% 
Grip Left   1  4  2  1      87.5% 
Reitan Finger Tapping Test   Rt   6  1  1        25% 
Reitan Finger Tapping Test   Lt  8            0% 
Grooved Pegboard Test   Rt   6  1    1      25% 
Grooved Pegboard Test   Lt   6  1    1      25% 
FAS Test  5  2      1    37.5% 
CALCAP Simple Reaction Time  3  2      1  2  62.5% 
CALCAP Choice Reaction Time  1  2      3  2  87.5% 
CALCAP Sequential Reaction 1  1  2  2  3      87.5% 
CALCAP Sequential Reaction 2  1  2  4  1      87.5% 
Short Term Verbal Memory  1  7          87.5% 
Long Term Verbal Memory  1  7          87.5% 
Short Term Non Verbal Memory  7    1        12.5% 
Long Term Non Verbal Memory  4  1  3        50% 
Category Test Errors  3    3  1      57.1% 
 
The results indicate that test scores of grip strength were found to be impaired 
among 100% of participants on their dominant side and 87.5% on the non dominant 
side, although the bulk of these were of a mild nature. 
Impairments on the Digit Symbol Subtest of the WAIS-III occurred in 87.5% of 
participants (mean 7.38) and the Symbol Digit Modalities Test (mean 43.88).  
These two tests comprise similar tasks of information processing speed.  Only 
60.5% of participants demonstrated impairments on the oral version of the 
SDMT (mean 49.00).  Among other subtests of the WAIS-III, 62.5% showed 
impairments on the Picture Arrangement test of picture sequencing (mean 
9.38), while 50% were impaired on the Letter Number Sequencing test (mean 
8.75) and the Digit Span test, (mean 9.88).  Both of these tests assess  
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concentration and attention span.  All other subtests of the WAIS-III showed 
impairments in none, one or only two individuals, so were not considered to be 
of significance. 
 
The National Adult Reading Test results of all eight individuals suggested that all 
pre-morbid IQ's would have been in the average to high average range (from 
108 to 116; Mean = 113), and their academic records supported these findings.  
Of the eight participants, 62.5% demonstrated losses in Full Scale, Verbal and 
Performance IQ‟s. 
 
Although memory deficits, as measured by the Wechsler Memory Scale - 
Russell Adaptation, were only mild, 87.5% of participants demonstrated 
impairments in both short and longer term verbal recall.  Only 12.5% of 
participants demonstrated mild to moderate impairment in short term non verbal 
recall, but 50% demonstrated mild to moderate impairments in longer term non 
verbal recall. 
 
The Trail Making test “A” of processing speed demonstrated only mild 
impairments in performance among 37.5% of the participants.  In the Trail 
Making test “B”, where there is another component involving the changing set 
from number to letter, there were also mild impairments in 37.5% of participants‟ 
scores.   
 
The overall mean scores for both “A” and “B” versions of this test were found to 
be below average.  
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The tests which were least sensitive to neurotoxic exposure were those of fine 
motor skills involving manual speed and manual dexterity.  Only 25% of the 
participants showed impairments in tapping speed and manual dexterity of their 
dominant hand.  Although 25% showed impairments in manual dexterity on the 
dominant side, none showed impairments in tapping speed on their non 
dominant side. 
 
3.6  Discussion 
Although a statistical analysis has not been carried out on these test results and 
there is no control group of individuals working in the same field but not exposed 
to BAe-146 jet engine oil emissions, it was considered that there were sufficient 
grounds to warrant further investigation of flight crew on BAe-146 aircraft. 
 
The above mentioned pattern of test results reflected studies carried out in other 
occupational settings, where workers were exposed to organo-phosphates, 
solvents and hypoxia (Winder, 2006).  According to Lezak, most chronic solvent 
toxicity occurs in workplaces as a result of long term exposure to fumes from 
such substances as paints, glues, cleaning fluids, petroleum fuel and lubricating 
and degreasing agents.  The most prominent cognitive deficits found among 
these groups involve many aspects of attention and memory and also response 
time slowing.  Lezak also reports that the transient effects of oxygen deprivation 
in high altitude environments, which have been studied in airline pilots can lead 
to mental dulling, diminished alertness with a loss of normal self-protective 
responses  (Lezak, 1995 & 2004). 
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The concerns regarding the health of pilots and flight crew of the BAe-146 were 
reflected in the outcome of the Senate Inquiry, which was tabled in Parliament in 
October 2000.  It read:  ”Eight recommendations were made with the aim of 
ensuring that appropriate assessments were carried out on the BAe-146 and 
other passenger aircraft, to ensure that proper standards of air quality are made 
mandatory for Australian aircraft, bearing in mind Australian operational 
activities”.  (SRRATR Committee Report 2000) 
 
The recommendations made by the Senate Inquiry were particularly addressed 
to CASA as the Australian Air Safety Agency, and the administrator of aircraft 
operating regulations and standards.  In addition, the Committee recommended 
that the Commonwealth initiate a number of responses to ensure that 
occupational health issues are addressed (Senate Rural and Regional Affairs 
and Transport References Committee, 2000). 
 
To discuss and explore the issues arising out of the Senate Inquiry in greater 
depth and to extend the debate about air quality in commercial aeroplanes, an 
Aviation Air Quality Symposium was held at UNSW and ADFA in Canberra in 
December 2000.  Eight papers were presented which covered the following 
topics:  Air Quality Monitoring; Aircrew Air and Passenger Health; Airworthiness;  
and Aircraft Engineering Concerns (Winder et al., 2000).  
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3.7  Conclusions 
Bearing in mind the above neuropsychological findings, coupled with the 
outcome of the Senate Inquiry, it was considered important to conduct a wider 
scale study of BAe-146 aircraft flight crew via a more comprehensive research 
study. 
 
The hypothesis of this follow on study would be that BAe-146 aircrew who have 
been exposed to engine fumes would demonstrate neuropsychological 
impairments on a number of neuropsychological measures. 
 
It was envisaged that an experimental group of at least 30 individuals could be 
administered the neuropsychological tests which proved most sensitive to the oil 
fumes in the Coxon study.  These test results could then be compared with a 
control group, of the same number of individuals who do not fly on the BAe-146 
and are therefore not exposed to the BAe-146 oil fumes.  The results would be 
statistically analysed by analysis of variance to determine the presence of any 
significant differences in test scores between the different groups‟ test scores. 
 
The data gathered from this recommended research project, if positive, could be 
used as evidence to initiate the introduction of better working conditions for 
employees in the aviation industry. 
 
Such a research project was conducted as a follow on study in the United 
Kingdom in 2006 with 27 airline pilots who had been exposed to jet engine fuel 
emission in the course of their work with different airline companies in the United  
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Kingdom and Europe.  This study was conducted in London after The Safety 
Committee for Airline Regulation deemed this necessary (Mackenzie-Ross, 
2006). 
 
The findings were sent to the United Kingdom Department for Transport and the 
UK Government agreed to fit air-monitoring equipment on aircraft.  It was 
admitted that there was a “large body of anecdotal and descriptive evidence 
linking ill-health among crew with poor air quality”.  However, The Department 
for Transport said that more work was needed to establish a definite link 
(Starmer-Smith, 2008). 
 
The outcome and conclusions of the above mentioned research project were 
that the pilots involved in the study were found to have similar cognitive deficits 
to those in the preliminary Western Australian study (Coxon 2005; Mackenzie-
Ross, 2006). 
 
The Mackenzie-Ross study, conducted at the University College in London 
revealed that all but one of the participants in the project showed significant 
cognitive impairments in speed of information processing, attention span and 
problem solving skills (Mackenzie-Ross, 2006). 
 
The Department for Transport in the United Kingdom stated that it takes the 
health of passengers and crew very seriously, but they also stated that it was not 
known what, if any, substances were in cabin air, and that is why they undertook 
the above mentioned research as a matter of priority (Starmer-Smith, 2008).  
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It was concluded that these cognitive impairments, although only of a mild 
nature could impact severely on affected pilots‟ capacity to safely control their 
aircraft.  The problem therefore is more than just a health hazard, it is also a 
serious flight safety problem.  There are a number of recorded cases by pilots 
having their judgement impaired, or of finding themselves rendered incapable of 
functioning due to the effects of contaminated air.  Research studies have 
demonstrated that 70% of plane crashes are caused by pilot error (Michaelis, 
2008; Loraine, 2007).  
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CHAPTER  4 
Neurotoxicity Problems Among Aircraft Engineers and the Psychological 
Effects on their Spouses 
4.1  Introduction 
An alarming situation has arisen in Australia over the past 30 years among 
RAAF aircraft maintenance engineers who had been exposed to jet fuels and 
toxic sealants as part of the F-III Deseal/Reseal Project.  This project took place 
over a 25 year period from early 1975 to late 1999 (RAAF/ADF, 2004). 
 
In 2001 the Royal Australian Air Force (RAAF) acknowledged that personnel 
involved in the F-III Deseal/Reseal program had been consistently exposed to 
chemicals (particularly solvents and sealants) known to be hazardous to human 
life (RAAF, 2001).  During this time, individuals had repeatedly reported acute 
and chronic symptoms of chemical poisoning such as mucosal membrane 
irritation, breathing difficulties, skin rashes, dizziness, mood changes and other 
psychiatric problems, motor dysfunction, gastro-intestinal problems, headaches, 
and cognitive dysfunction including loss of memory and poor concentration.  
Even now, some thirty years or so after the program‟s inception, individuals who 
were involved in the F-III Deseal/Reseal program are continuing to report some 
of the longer term effects of the chemical exposure including various cancers 
and growths, infertility, hepatic and kidney dysfunction, and lasting cognitive 
deficits.  After such a lengthy period of time the effects on the health of these 
exposed workers are likely to be permanent, without any possibility of reversal 
of their symptoms.  There is a possibility that long-term solvent exposure may  
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ultimately produce an Alzheimer – like dementia, as found in chronically 
exposed painters (Lezak, 2004). 
 
Even in the absence of a frank dementia, solvent exposure may contribute to 
poorer cognitive functioning by interacting with the normal aging process (Nilson 
et al., 2002). 
 
4.2  Magnitude of the Problem 
Approximately 700 RAAF aircraft maintenance workers were involved in the 
Deseal/Reseal Program over a 25 year period, which resulted in significant 
health problems.  When these health problems were identified, the program was 
terminated.  The RAAF  accepted liability and conducted a wide scale 
assessment of the health effects of the workers involved in the program.  This 
wide scale health study resulted in the publication of “Study of Health Outcomes 
in Aircraft Maintenance Personnel” (SHOAMP), in September 2004. 
 
4.3  Details of the Study 
There were 659 exposed workers and 1095 controls in the study:  They were all 
assessed on a number of measures for: 





Sexual dysfunction  
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Mental health problems 
Neuropsychological deficits 
 
Many health outcomes emerged from this study, but those related to 
neuropsychology which were of significance were; lowered performances on 
tests of;  executive functioning, problem solving, processing speed, memory 
capacity, and new learning skills. 
 
It was found that the most toxic component of the desealing agent used was a 
chemical known as SR51.  This sealant contained 75% solvesso150, which is a 
mixture of aromatic hydrocarbons.  It also contained 10% Dimethylacetamide, 
10% Thiophenol and 5% Triethylphosphate.  With both organic solvents and an 
organophosphate present, this chemical has a neurotoxic potential.  In all the 
analyses carried out, this particular chemical agent demonstrated the most wide 
spread symptoms and health effects (RAAF/ADF, 2004). 
 
As a result of the above study, it became evident that the health of many of 
these individuals had been significantly compromised as a result of being 
involved in the F-III Deseal/Reseal program. 
 
However, what was less clear was the impact that their chronic illness had on 
their partners and spouses. 
 
Research has indicated that chronic illness can have a profound effect on the 
family members of the individuals involved, particularly on the spouse, who is  
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generally the primary caregiver (Horowitz, 1985).  Many partners feel obliged to 
provide 24 hour a day, informal, unpaid care for their family member who has 
experienced a serious illness or injury.  Research has revealed that previously 
healthy spouses often find themselves developing a variety of physical and 
mental health problems within two years of the onset of a serious illness or 
injury of a family member, thought to be due to the stress associated with this 
burden of care (Cantor, 1983). 
 
The present research project endeavoured to ascertain the psychological 
implications for spouses and partners of the F-III Deseal/Reseal program 
personnel who suffered chemical injuries.   
 
Stress as a concept is difficult to define, due to the subjective nature of the 
experience for the individuals involved.  However, it is often conceptualised as 
psychological distress occurring in situations in which the demands of the 
situation are perceived to tax or exceed the individual‟s available resources 
(Lazarus & Folkman, 1984).  The level of perceived stress by the individual is 
determined by the interaction of: (a) a primary appraisal of the event as 
involving harm, threat of harm, or challenge; (b) a secondary appraisal 
identifying available coping resources; and (c) a coping response (Chwalisz, 
1996).  Chronic stress can be associated with illnesses such as high blood 
pressure, irritable bowel syndrome and respiratory difficulties, and also with 
disease progression in persons who are already unwell (Greenwood, Muir, 
Packham, & Madeley, 1996).  The mechanism of this action is as yet relatively 
unclear, however it appears that there are at least two major interactions  
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associated with stress related illnesses.  These are; firstly, the action of the 
stress hormones cortisol, epinephrine, and norepinephrine stimulating 
peripheral activity, which can lead to “wear-and-tear” on cells from repeated 
arousal and inefficient control of physiological responses (McEwen, 2000); and 
secondly, the triggering of compensatory risky health behaviours stemming from 
poor coping strategies such as; poor diet, sedentary behaviour, and substance 
abuse (Vitaliano, Zhang, & Scanlan, 2003).  
 
The effects of caregiver stress can be both physical and psychological in 
nature.  For example, a meta-analysis of 23 studies found that caregivers had a 
23% higher level of stress hormones than demographically matched controls, 
and concluded that the act of caregiving significantly influenced the physical 
health of the caregiver (Vitaliano et al., 2003).  One identified psychosocial 
response to the stress of caregiving is the perceived burden of care.  It results 
from the physical, psychological, emotional, social and financial problems 
experienced by families caring for impaired adults (George & Gwyther, 1986). 
Burden can manifest as feelings of embarrassment, overload, depression, 
anxiety, entrapment, resentment, isolation from friends and family, loss of 
control, and poor communication (Zarit, Reever, & Bach-Peterson, 1980).  
Given that the stress that is felt by a caregiver of a person with a progressive 
condition, such a chemical poisoning, is likely to be both prolonged and 
intractable, it is not surprising then that these caregivers often report more 
perceived distress, physical health complaints, and risky health behaviours than 
do non-caregivers. 
  
  54 
One of the more under researched areas of caregiver burden is the 
psychosocial impact of caregiving both directly and indirectly.  Research has 
demonstrated that providing care to a family member is associated with 
increased psychological distress (Donaldson, Tarrier, & Burns, 1998).  For 
example, up to 48% of dementia caregivers have been identified as being at 
risk for psychiatric symptomatology (Draper, Poulos, Cole, Poulos, & Ehrlich, 
1992).  Often caregivers are faced with difficult caregiving tasks and also 
behavioural problems of their care recipients, such as verbal and physical 
aggression and confusion (Teri, Truax, Logsdon, Uomoto, Zarit, & Vitaliano, 
1992).  Additionally, providing care to a disabled relative often restricts the 
personal life, social life, and employment of the caregiver.  For example, 
caregivers may have less time to spend with friends, to fulfil other family 
obligations, or to pursue leisure pursuits (Zarit et al., 1980).  A meta analysis of 
84 studies relating to the psychological and physical health of caregivers 
determined that caregivers are consistently more stressed, depressed, and 
have lower levels of subjective well-being, physical health, and self-efficacy 
than non-caregivers (Pinquart & Sorensen, 2003). 
 
Given that it is evident that there can be a wide range of negative consequences 
on the psychological and physical health of caregivers and family members, the 
present research attempted to determine whether there is a psychological effect 
on the spouses of the F-III Deseal/Reseal program personnel in order to 
document and define any impact that the program has had in a wider sense, than 
just the personnel themselves.  It was postulated that there would be a statistically 
significant difference in the psychological functioning of the spouses of the  
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individuals involved in the F-III Deseal/Reseal program.  Given the previous 
research with spouses of individuals suffering chronic illnesses, it was 
hypothesised that the spouses of individuals involved in the F-III Deseal/Reseal 
program would demonstrate higher levels of depression, anxiety, and stress than 
spouses of individuals not involved in the F-III Deseal/Reseal program. 
 
4.4  Method 
Phase 1 – Preliminary Study 
In order to obtain a sense of the variety and magnitude of issues involved in 
caregiving for individuals involved in the F-III Deseal/Reseal program and to 
develop and select the appropriate questionnaires for the main study, a 
preliminary study was conducted involving a small sample of spouses of the 
affected individuals.  The Chief Researcher met with six F-III Deseal/Reseal 
program spouses over a two day period In Brisbane Queensland to conduct 
structured interviews and psychological  assessments of each individual.  The 
Personality Assessment Inventory (PAI); (Morey, 1991) and a range of burden 
of care questionnaires were administered.  These included the Zarit Burden 
Inventory (ZBI); (Zarit et al., 1980) and other questionnaires researched via 
PsycINFO.  
 
The six participants then rated the questionnaires for their appropriateness in 
representing the difficulties they faced in caring for their chemically affected 
spouses.  Some of their spouses were severely affected by the chemicals and 
were home bound, being unable to drive a vehicle or leave the home without a 
carer present.  Among the burden of care questionnaires, the ZBI was rated the  
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most useful in terms of delineating burden of care, and five of the six individuals 
obtained scores which placed them in the moderate to severe range.  All of the 
preliminary study participants‟ PAI profiles demonstrated significant peaks on 
the Depression scale,  the Somatic Complaints scale, and the Anxiety and 
Stress scales,  across all participants.  
 
Information collected from the structured interview outlining the problematic 
issues faced by these individuals in caring for their disabled spouses was 
collated and transformed into a 28-item questionnaire entitled the “Spouse 
Questionnaire” (SQ).  The draft questionnaire was then reviewed by the 
representatives of the spouse group and the RAAF project manager and the 
necessary modifications were made.  This preliminary study resulted in the 
selection of the assessment instruments deemed most appropriate for the F-III 
Deseal/Reseal program spouse study, that is, the PAI, the ZBI, and the SQ. 
 
Phase 2 – Main Study 
Experimental Group 
The experimenters obtained a list of spouses and partners of the F-III 
Deseal/Reseal program personnel who had consented to participate in the 
study from the RAAF.  Of the 110 individuals invited to participate, 91 
completed the questionnaires sent out to them, indicating a response rate of 
83%.  The age of the participants ranged from 27-73 years (mean = 49) and all 
were female. 
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Control Group 
The experimenters obtained a list of spouses and partners of personnel who 
had not been involved in the F-III Deseal/Reseal program who had consented to 
participate in the study from the RAAF.  These spouses were not in a situation 
where they had to care for non chemically injured workers.  Some of them had 
retired spouses.  Of the 52 individuals invited to participate, 25 completed the 
questionnaires sent out to them, indicating a response rate of 48%.  The age of 
the participants ranged from 34-69 years (mean = 47.1).  Twenty one of the 
participants were female and four were male.  The size of the Control Group 
was considered adequate for statistical power.  It was not considered that the 
inclusion of male carers would add bias to the study. 
 
4.5  Measures 
Personality Assessment Inventory (PAI).  The PAI is a self-administered, 
objective inventory of adult personality and psychopathology.  The PAI contains 
344 items comprising 22 non-overlapping full scales, including four validity 
scales; (Inconsistency, Infrequency, Positive Impression and Negative 
Impression) eleven clinical scales; (Somatic Complaints, Anxiety, Anxiety 
Related Disorders, Mania, Paranoia, Schizophrenia, Borderline Features, Anti-
Social Features, Alcohol Problems, Drug Problems); five treatment scales; 
(Aggression, Stress, Non Support, Suicidal Ideation, and Treatment Rejection); 
and two interpersonal scales; (Dominance and Warmth)  (Morey, 1991).  In 
addition to the measurement of clinical constructs, interpretation of results also 
provides measures for detecting attempts to feign or manipulate symptomology 
as well as an assessment for the individual‟s motivation for treatment.   
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Respondents are asked to indicate to what extent they believe the statements in 
the test are an accurate representation of themselves on a 4-point ordinal scale 
(F = False; ST = Slightly True; MT = Mainly True; VT = Very True).  
Zarit Burden Inventory (ZBI).  The ZBI is a 22-item measure of the perceived 
impact of caregiving on the caregiver's financial status, physical health, 
emotional health, and social activities (Zarit et al., 1980).  The respondents 
indicate on a 5-point scale describing how much each statement applies to him 
or her, ranging from “Never” to “Nearly Always”.  The maximum score possible 
on the ZBI is 88 and a high score is indicative of higher levels of perceived 
burden of care. 
Spouse Questionnaire (SQ).  The SQ was developed using the information 
obtained from the participants in the preliminary phase of the study.  It 
contained 28 questions relating to feelings and emotions commonly associated 
with caregiving burden such as stress, and social isolation (e.g., “Do you feel 
that you are currently under a great deal of pressure?, “Do you feel rejected by 
family and friends?”).  The respondents indicate on a 4-point scale describing 
how much each statement applies to him or her ranging from “Not at all” to 
“Always”. 
 
4.6  Procedure 
Each of the 162 spouses invited to become involved in the research were 
mailed a package containing a consent form, the PAI question booklet, a PAI 
HS Answer Sheet, the SQ, and an information sheet outlining the procedures 
related to correctly completing the questionnaires (e.g. test instructions).  
  59 
Additionally, packages mailed to the Experimental Group included the ZBI (as 
this is an inventory that is highly specific to caregivers it was deemed 
inappropriate to give to the Control Group).  Participants were instructed to 
return the completed packages along with their signed consent form, in a self-
addressed, reply paid envelope, provided by the researchers.  Reminder letters 
were sent to those participants who had not returned their packages after a 
period of four weeks.  In addition, letters and additional self-addressed reply 
paid envelopes were sent to participants who had returned incomplete 
packages (e.g., missing questionnaires or unsigned consent forms).  Altogether 
122 packages were returned, however of these six packages were excluded 
from further analysis.  Of these six, three were excluded because the consent 
form had not been signed despite further written requests, and three because it 
was clear that the individual involved in the F-III Deseal/Reseal program had 
filled in the questionnaires and not the spouse.  These individuals were sent 
new packages with a request for the spouse to fill them out, however they were 
not returned. 
 
The PAI and ZBI were scored according to the procedures determined by their 
original authors.  The SQ was scored by coding each of the four points on the 
answer scale (e.g., “Not At All” = 0, “Always” = 3), followed by reverse coding 
three of the negative items, then summing all the items.  Data analysis was 
completed using computer software designed for inferential statistics.  Ethics 
approval for this research project had been granted by the Murdoch University 
Ethics Committee and written informed consent was obtained from all study 
participants.  
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4.7  Results 
Independent sample t-tests were carried out to determine whether there was a 
difference on the PAI validity scales, between the Experimental Group and the 
Control Group.  No significant differences were found between the two groups, 
on the four validity scales (Inconsistency; t = 1.50, p = 0.14; Infrequency; t = 
0.787, p = 0.43; Negative Impression; t = 1.48, p = 0.14; and Positive 
Impression; t = 1.48, p = 0.14).  This indicates that both groups attended to the 
items consistently and appropriately, and did not attempt to present an 
unrealistically favourable or negative impression. 
 
Independent sample t-tests were also performed to determine whether 
participants assigned to the Experimental Group reported higher levels on the 
clinical scales of the PAI, than those in the Control Group.  Of the 11 scales, 
significant differences were found between the groups on four of these: Somatic 
Complaints, Anxiety, Depression and Antisocial Features.  The Experimental 
Group reported higher levels of Somatic Complaints (t = 3.06, p = 0.002), Anxiety 
(t = 3.62, p = 0.0004), and Depression (t = 2.76, p = 0.0068).  The Control Group 
scored higher on the Antisocial Features scale (t= -2.33, p = 0.02), when 
compared to the Experimental Group.  However on further analysis of the 
individual participant data pertaining to this scale, it appears that the mean 
obtained had been highly influenced by three unusually elevated outliers.  On 
removal of these outliers there was no significant difference between the two 
groups (t = 0.9, p = 0.37) and thus this anomaly is excluded from further 
discussion.   
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Four independent sample t-tests were carried out to determine whether 
participants in the Experimental Group obtained higher scores on the treatment 
scales of Aggression, Suicide, Stress, Non-Support, and Treatment Rejection 
than those in the Control Group.  The Experimental Group reported significantly 
higher levels of Stress (t = 3.61, p = 0.0004) when compared to the Control 
Group.  There was no significant difference between the groups on the levels of 
Aggression, Suicidal Ideation, Non Support or Treatment Rejection. 
 
TABLE   IX 
Comparison of group means for Experimental and Control Groups 




SD  T-Values  Significance 
Validity Scales           
Inconsistency  51.5  48.3  9.37  t = 1.50,df=1142  p = 0.14 (ns) 
Infrequency  50.3  51.8  8.24  t = 0.787,df=114  p = 0.43 (ns) 
Negative Imp   56.7  52.7  11.9  t = 1.48,df=114  p = 0.14 (ns) 
Positive Imp   49.2  51.4  10.7  t = 0.928,df=114  p = 0.36 (ns) 
Clinical Scales           
Somatization  60.5  51.2  13.5  t = 3.06,df=114  p = 0.0028 ** 
Anxiety  61.7  51.9  12.0  t = 3.62,df=114  p = 0.0004 *** 
Anxiety Disorders  57.4  53.4  12.2  t = 1.47,df=114  p = 0.14 (ns) 
Depression  65.3  56.9  13.5  t = 2.76,df=114  p = 0.0068 * 
Mania  46.6  47.9  9.71  t=-0.607,df=114  p=0.55 
Paranoia  52.6  52.8  11.0  t=0.66E-01,df=114  p=0.95 
Schizophrenia  57.1  52.3  13.4  t=1.57,df=114  p=0.12 
Borderline  55.1  52.7  11.7  t=0.926,df=114  p=0.36 
Antisocial Features  43.6  47.5  6.84  t=2.50,df=114  p=0.014 
Alcohol  48.5  51.4  9.18  t=-1.40,df=114  p=0.16 
Drug  49.6  49  7.45  t=0.326,df=114  p=0.74 
Treatment Scales           
Aggression  48.2  50.3  11.3  t=0.805,df=114  p=0.42 
Suicide  55.1  50.2  15.0  t = 1.46,df=114  p = 0.15 (ns) 
Stress  57.1  48.8  10.1  t = 3.61,df=114  p = 0.0004 *** 
Non support  53.2  50.0  11.3  t=1.25,df=114  p=0.21 
Treatment Rejection   49.7  52.4    t = 1.27,df=114   
Interpersonal Scales           
Dominance  44.8  46.5  10.0  t=-0.731,df=114  p=0.47 
Warmth  47.3  47.3  10.6  t=-0.549E-03,df=114  p=1.00 
Spouse Q   38.7  20.8  13.0  t = 6.05,df=113  p = 0.0001*** 
Zarit Burden Q  41.4  N/A  N/A  N/A  N/A 
 
NB: NS = p>0.05, * = p<0.05, ** = p<0.005, *** = p<0.0005 
 
An independent sample t-test was used to determine whether there was a 
difference on the SQ scores between the Experimental Group and the Control  
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Group.  The Experimental Group scored very significantly higher (t = 6.05, 
p<0.0001) on this measure of distress than the Control Group.  
The ZBI scores were calculated only for the Experimental Group to determine 
their level of burden of care (mean = 41.42).  This score indicated that they had 
experienced a Moderate to Severe level of stress in caring for their disabled 
spouses compared with test normative data.  This score does not include 
factors regarding whether or not the carer perceived that the care would be 
required indefinitely.  
 
4.8  Discussion 
The results of the study indicate that there are significant deleterious effects on 
the psychological functioning of spouses of individuals involved in the F-III 
Deseal/Reseal program as a result of the program itself.  While only a limited 
number of control participants took part in the study, some very robust results 
were obtained at high levels of significance.  Therefore, the results of the study 
can be taken at face value despite such limitations, as it is unlikely that anything 
different would be obtained with a larger control sample.   
 
In addition to the significant differences between the Experimental and Control 
Groups on the PAI clinical scales of Somatic Complaints, Anxiety, and 
Depression, the scores for the Experimental Group fell into the significantly 
elevated range when compared to a normative population sample.  According to 
Morey (1996), when Somatic Complaints scores are between 60 and 69 such 
as those in the Experimental Group (mean = 61), it reflects individuals with 
concerns about health functioning which would not be uncommon in individuals  
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with specific medical conditions, and those under significant levels of stress. 
Anxiety scores in the range between 60 and 69 as were seen in the 
Experimental Group (mean = 62) represented individuals who were likely to be 
experiencing stress and be worried, sensitive and emotional.  Depression 
scores between 60 and 69 such as those in the Experimental Group (mean = 
65) indicate a group of people who were likely to be unhappy, sensitive, 
pessimistic and self doubting.  However, the below average Treatment 
Rejection scores from 43 to 52 like those obtained by the Experimental Group 
(mean = 48) indicate that they;  were willing to acknowledge the need to make 
some changes to their life; had a positive attitude to the possibility of change; 
and accepted the importance of personal responsibility.  Conversely, among the 
Control Group participants scores there were no significant elevations on the 
PAI scales compared to a normative population sample.  The Treatment 
Rejection scores in this Control Group (mean = 52.4) indicated individuals who 
are generally satisfied with themselves and see little need for major changes in 
their cognitions, emotions, and behaviour.   
 
It was determined that 63.73% of the Experimental Group obtained significantly 
elevated Depression Scores (i.e., scores over 60) ranging from 60 to 108, some 
of whom (25.27%) had highly elevated Suicidal Ideation scores.  This sub-group 
was then separated out to determined the potential for suicide via the Suicide 
Potential Index (SPI) of the PAI.  The mean SPI for this sub-group was 10.09 
which indicated that they were in the low category for suicide risk (Morey, 
1996).  However, as some group members had extremely elevated Suicidal 
Ideation scores in addition to high levels of Depression, Anxiety, and Stress, it  
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was considered prudent to calculate the sub-group‟s potential response to 
treatment and the likelihood of treatment success via the Treatment Process 
Index (TPI) of the PAI.  This sub-group had a mean TPI of 2.8 which indicated 
the presence of numerous personal assets that may assist in the treatment 
process (Morey, 1996).  This low TPI in consideration with a below average 
Treatment Rejection Score, suggests that these individuals acknowledge that 
they have significant problems and perceive that they have a need for 
assistance in dealing with their problems.  In volunteering to participate in this 
study, one could well suggest that these spouses had an expectation of 
assistance, hence their low TPI score.  However, this was not offered to them 
initially.  Every spouse of the F-III Deseal/Reseal participants was contacted to 
participate in the study, consequently it was considered to be a representative 
sample of spouses.  People in this category reported a positive attitude towards 
the possibility of personal change, and recognised the value of therapy and the 
importance of personal responsibility.  They seem interested and willing to 
engage in introspection, in order to bring about self-improvement (Morey, 1996).  
Therefore, the TPI and SPI of this sub-group indicated that participants who had 
elevated Suicidal Ideation scores would be in the low risk group for suicidal or 
self-harm behaviours, but would be likely to respond well to treatment, given 
that they acknowledged and perceived a need for help in dealing with their 
problems.  Bearing in mind these important factors, if treatment were offered to 
members of the Experimental Group, who were suffering significant emotional 
distress, it is likely that they would respond well to this offer and that the 
resources provided would be well utilised.  
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4.9  Conclusions 
As the literature indicates, individuals enduring the burden of caring for their 
chronically ill and disabled spouses are likely to suffer emotional and physical 
distress themselves.  The present research project supports these findings and 
clearly demonstrates the levels of somatic or physical health complaints, plus 
the anxiety, depression and stress that the spouses and partners of F-III 
Deseal/Reseal program personnel have suffered as a result of their caring role. 
 
The SQ, which was constructed to outline the problems faced by the F-III 
Deseal/Reseal program spouses, demonstrates its usefulness in delineating the 
specific difficulties experienced by these individuals.  The difference between 
the Experimental and Control Groups was extremely significant at a probability 
level of 0.0001, highlighting the unique problems faced by the spouses of the  
F-III Deseal/Reseal program personnel.  As the ZBI placed the F-III Deseal/Reseal 
program spouses in the Moderate to Severe range for burden of care, compared 
to a normative sample, it demonstrates that this group of individuals is struggling 
to cope with the burden of care placed upon them.  Some of these individuals 
recorded significantly high suicidal ideation scores as well, which indicates their 
potential risk for self harm.  These high scores also indicated that their level of 
psychological distress was beginning to exceed their available coping strategies.   
 
Given that there is clear evidence to suggest that the F-III Deseal/Reseal 
program has had a deleterious effect on the psychological functioning of the 
spouses of the individuals involved, it was considered responsible for the 
research project organisers to offer appropriate evidence based psychological  
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treatment for this group, focusing on the areas of most concern.  These areas 
are;  stress, depression, anxiety, suicidal ideation, generalised coping strategies 
and physical health problems.  Such treatments could be, cognitive behavioural 
therapy focused on anxiety or depression, schema focussed therapy and other 
therapies approved by the Australian Psychological Society for the treatment of 
such conditions.  Other suggested interventions could include the development 
of weekly support groups,  funded by the RAAF, where the spouses could have 
an outlet to discuss and vent emotional distress with other individuals in similar 
situations and circumstances and to facilitate more effective coping strategies.  
 
 Additionally, regularly funded respite breaks would be recommended for the 
spouses to enable them to engage in self-care activities to increase their 
resilience to the psychological distresses they face on a daily basis.  As the 
above results have demonstrated a willingness for treatment and the likelihood 
of positive treatment outcomes for members of the Experimental Group, any 
future resources allocated for this purpose would be likely to be well utilised by 
these individuals.   
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CHAPTER  5 
Neurotoxicity in Hospital Settings 
5.1  Introduction 
 
Most of the research on neurotoxicity has been conducted in the areas of 
manufacturing, agriculture, mining and aviation settings.  Some research has 
also been conducted on Health Care Workers who have been exposed to 
chemicals in the course of their work, such as those working in laboratories 
where they are exposed to formaldehyde and other preservative agents.  
However, little research has been conducted into the effects of sterilization 
agents such as Glutaraldehyde on the workers who handle such chemicals.  
The research which has been conducted has focused mainly on the general 
health problems associated these sterilization agents, such as respiratory tract 
disorders, skin rashes and chronic fatigue;  but very few studies have actually 
addressed the neuropsychological impact of these chemicals on exposed health 
care workers  This is despite the frequent complaints of cognitive difficulties, 
such as “fogginess” in the head, confusion, memory lapses, “spacing out”, and 
poor concentration. 
 
Glutaraldehyde is an aliphatic aldehyde of molecular formula C5H8O2.  The 
chemical is not manufactured in Australia, but it is commercially available here.  
It is distributed as a clear aqueous solution at concentrations up to 50% WW 
(NICNAS, 1994). 
 
Glutaraldehyde is a chemical used extensively in hospitals and dental surgeries 
as a convenient disinfectant for optic fibre endoscopes and other delicate  
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medical instruments.  It is effective against viruses and bacteria and is used as 
a 1% or 2% solution in instrument disinfecting.  It is also used as a biocide in 
cooling towers and as a fixative in microbiology and histopathology laboratories.  
It is a tanning agent for leather and is also used as a component of the 
developer solutions which are used in x-ray film processing. 
 
Glutaraldehyde was first synthesised around 1908, and as health concerns 
about formaldehyde emerged, its usage increased (SNFTAAS, 1999). 
 
In the 1960‟s and 70‟s, Glutaraldehyde was used mainly as a fixative in 
histology laboratories, and as a hardener in x-ray developer solutions and as 
such was used by only a small number of workers.  But in the late 1960's 
Glutaraldehyde was documented as being a useful cold sterilizing agent for 
urological instruments, clinical thermometers, and dental instruments and was 
therefore used more frequently (O‟Brien, Mitchell, Haberman, Rowan, Winford & 
Pellet, 1966; Lane, McKeevor & Fallon, 1996; Metzger, 1967).  With the advent 
of the HIV problem in the 1980‟s there was a re-evaluation of the efficacy of 
cold sterilization agents in use at the time, and some agents were not 
considered adequate to destroy the AIDS Virus.  Hence Glutaraldehyde was 
suggested as a more effective alternative in hospitals and surgeries (Menzies, 
1995). 
 
This meant that the risks of Glutaraldehyde poisoning rose as: 
  Greater volumes of Glutaraldehyde were being used 
  More workers were exposed to Glutaraldehyde  
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  The controls for Glutaraldehyde were poor, in terms of ventilation, 
protective clothing and storage methods (Ellett, Mikels & Fullhart, 1994). 
  Lack of written policies on correct usage of Glutaraldehyde 
 
5.2  Human Studies 
The first reported adverse health reaction to Glutaraldehyde was published in 
the British Medical Journal in 1968, and it was concerned with contact 
dermatitis (Sanderson & Cronin, 1968).  However, the most serious problems 
documented nowadays are; irritations to the nose and throat; general tightness 
of the chest; occupational asthma; rhinitis; and eye irritations.  These problems 
have been experienced by health care workers exposed to Glutaraldehyde  
vapours of varying concentrations (NICNAS, 1994 & 1997; Norback, 1988; 
Newman & Kachuba, 1992; Tkaczuk et al., 1993; Cullinan, 1992; Ellett, Fullhart 
& Wright, 1996; Photosol Ltd, 1999).  Connaughton, reported palpitations and 
tachycardia in seven health care workers exposed regularly to Glutaraldehyde 
(Connaughton, 1993). 
 
In two more recent studies with dental workers exposed to Glutaraldehyde and 
formaldehyde it was found that dental hygienists and dental assistants who 
sterilize dental instruments are suffering allergic contact dermatitis.  In one 
study by Ravis et al with  101 dental workers found that almost 15% were 
found to be allergic to Glutaraldehyde.  Given that chronic occupational skin 
disease has a relatively poor prognosis, it was considered imperative that 
dental care workers be educated about proper hand hygiene, to avoid potential  
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allergens and chemical exposure and to recognize problems early (Ravis et al., 
2003; Hamann et al., 2005). 
 
As documented in NICNAS, Glutaraldehyde has been added to the indicative list 
of respiratory sensitisers on the recommendation of the Industrial Injuries 
Advisory Committee as a chemical that may cause occupational asthma 
(NICNAS, 1994 & 1997). 
 
The above mentioned research studies, investigating the effects of 
Glutaraldehyde on health care workers focus almost entirely on physical, 
dermatological and respiratory symptoms.  However, individuals exposed to 
Glutaraldehyde often report cognitive difficulties such as attention and 
concentration problems, memory deficits, problems solving difficulties and 
slowed information processing speed (Glass, 1997; Coxon, 1998; Davis, 2002).   
 
Despite these cognitive difficulties, which have often been reported to medical 
professionals, little attention appears to have been devoted to them.  
Investigation of these reported difficulties via comprehensive 
neuropsychological assessments, appears to have been infrequent. 
 
Lezak states that the lack of investigation of cognitive problems among 
chemically exposed workers generally occurs because of the similarity of some 
of these complaints to those of neuroticism or depression.  This, coupled with 
the absence of distinct neurological symptoms, can lead the naïve investigator 
into discounting the worker‟s complaints of cognitive deficits.  However, where  
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neuropsychological evidence is available, symptoms are often supported by 
positive objective findings (Lezak, 1995). 
 
5.3  Neurotoxic Effects of Glutaraldehyde 
One brief neurophysiological study was conducted in New South Wales in the 
1990‟s investigating the effects of Glutaraldehyde on brain function. 
 
Dr Richard Teo investigated the Auditory Evoked Response Potentials (AERP) 
of health care workers exposed to Glutaraldehyde in an endoscopy unit for 
various periods of time.  Teo's study included three health care workers 
exposed to Glutaraldehyde for varying periods of time.  However there were no 
specific details of the total duration of exposure to the chemical of any of the 
three participants in the study.  The only measure of impairment was the P300 
latency component of the AERP recording, and there was no control group to 
verify Teo's findings.  However, Teo concluded that his test results suggested 
that the participants' rate of response to stimuli, as reflected in the P300 
component, was impaired.  He postulated that these impairments were due to 
the effects of low dose Glutaraldehyde exposure (Teo & Naidu, 1994). 
 
Although the above study is not robust nor is it statistically sound, the findings 
support subjective reports of cognitive deficits among health care workers 
exposed to Glutaraldehyde. 
 
Another early study conducted by Dorothy Gronwall from New Zealand, 
assessed a small group of health care workers who were exposed to the  
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chemical Glutaraldehyde, which was being used as a cold sterilization agent for 
endoscopes.  Although the findings were significant, and all three nurses were 
found to have deficits in information processing speed, concentration span and 
working memory, there was no control group in the study and no details of any 
protective measures used by the individuals involved were taken into account.  
This study did not document the quality of ventilation systems involved in each of 
the work settings, nor did it take into account the concentration of the chemical 
used, or the weekly duration of use by the workers involved (Gronwall, 1997). 
 
The inclusion of this type of data would have added significant weight to the 
study.  The inclusion of more informative data may also have had an impact on 
the safety monitoring of work settings where Glutaraldehyde was being used.  
This may have led to earlier changes in cold sterilization use, so that less 
individuals working in this industry would have suffered cognitive decline.  
Perhaps if this were used as a preliminary study in New Zealand, then a more 
robust study could have followed, with more conclusive results. 
 
5.4  Background to the Present Proposed Study 
There is evidence in the literature that health care workers in endoscopy units, 
veterinary surgeries, x-ray departments, dental surgeries and hospital operating 
theatres have experienced concentration and memory difficulties, and slowed 
speed of information processing (Glass, 1997; Coxon, 1998; Davis, 2002).  
Complaints regarding the above mentioned problems have been made by 
workers who were regularly exposed to 1% and 2% solutions of Glutaraldehyde  
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over prolonged periods of time, sometimes up to twenty years of accumulated 
exposure.   
Complaints such as these from several workers, led to the decision to conduct 
an investigation of the problem. 
 
5.5  Preliminary Study 
In the course of clinical practice during 1995 and 1996, two endoscopy unit 
nurses, one dental technician and one x-ray assistant, who were exposed to 
Glutaraldehyde in the course of their work, were interviewed and assessed 
psychometrically.  The dental technician and one of the endoscopy unit nurses 
had the most intense and direct exposure to Glutaraldehyde, as they 
experienced both skin contact and inhalation of the chemical.  They were 
exposed to Glutaraldehyde for periods of 18 months and 15 months 
respectively.  As well as their reported cognitive changes, they were found to 
have EEG changes and both had experienced seizures.  The endoscopy unit 
nurse and the x-ray assistant were exposed to Glutaraldehyde for longer 
periods, (8 and 9 years, respectively), but their exposure was less intense and 
their problems were found to be less severe (Coxon, 1998 & 1999). 
 
All four individuals were administered components of the Halstead Reitan 
Battery of tests, the Spielberger Anxiety Inventory and the Beck Depression 
Inventory.  On assessment, the most commonly occurring neuropsychological 
deficits which were found among these four health care workers were: 
  Lowered attention span (Digit Span Subtest of the WAIS-R) 
  Short term memory problems  (Wechsler Memory Scale – Russell Revision)  
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  Slowed speed of information processing  (Digit Symbol and Trail Making tests) 
  Lowered manual speed (Reitan Finger Tapping test) 
  Lowered manual dexterity  (Grooved Pegboard test) 
  Significant levels of anxiety and depression were found  (Spielberger Anxiety 
Inventory and Beck Depression Inventory) 
 
These four individuals fell into two distinct groups:- 
 
Group  1 
These two health care workers were exposed more acutely to higher 
concentrations of Glutaraldehyde over shorter periods of time with few 
protective measures (15 to 18 months), and they suffered the greatest 
neuropsychological impairments. 
 
Group  2 
These two health care workers were exposed less severely to low 
concentrations of Glutaraldehyde over prolonged periods of time (8 to 9 years) 
and suffered less severe impairments. 
 
Due to the relatively significant findings from the above mentioned case 
studies, which supported the previous findings of Teo, Naidu and Gronwall, a 
wider scale research project was proposed to investigate the effects of 
Glutaraldehyde use on health care workers (Teo & Naidu, 1994; Gronwall, 
1997).  
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5.6  The Proposed Glutaraldehyde Study 
The purpose of the current study was to determine the extent of cognitive 
impairment if any, experienced by a group of health care workers exposed to 
Glutaraldehyde.  The study also aimed to verify the findings of Teo and Naidu, 
that health care workers exposed to low doses of Glutaraldehyde solutions 
have impairments in their rate of response to stimuli (Teo & Naidu, 1994). 
 
The proposed study also examined the effects of Glutaraldehyde use on the 
emotional state of the workers involved. 
 
Among the above mentioned groups of workers in medical, and aviation 
industries, there were found to be some common areas of neuropsychological 
deficit.  These deficits were found in; memory functioning, processing speed, 
reaction time, attention span and some aspects of fine motor skills. 
 
Although industrialization is considered a necessary feature of economic 
growth, it does bring with it occupational health and safety problems.  With the 
increasing incidence of occupational neurotoxic diseases there is a demand for 
safer working conditions, better occupational health services and a broader 
coverage of health education. 
 
By conducting studies such as this, with individuals exposed to Glutaraldehyde 
and other chemicals, researchers can acquire a greater understanding of the 
effects of chemicals on the human central nervous system.  This can also  
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assist workers to become more mindful of the necessity for using protective 
measures in all workplaces, to reduce the occurrence of neurotoxic illnesses. 
 
5.7  Assessment Methods Used 
Assessment methods utilized previously in the literature on neurotoxicity have 
included a range of commonly used neuropsychological test batteries, 
including; the Halstead Reitan Battery of Tests; the Wechsler Adult Intelligence 
Scales; Wechsler Memory Scales; various tests of Reaction Time; Executive 
Functioning tests; Fine Motor Skills tests to assess the Peripheral Nervous 
System; and other tests utilizing Electro Encephalograph (EEG) readings, such 
as the P300 or P100 readings. 
 
The most meaningful results in assessing individuals with reported cognitive 
deficits following chemical injuries have been via the most sensitive of the 
Wechsler Intelligence Scale Subtests, the Digit Symbol and Digit Span tests, 
which assess processing speed and attention span, respectively.  The Paired 
Associate Test from the Wechsler Memory Scale-Revised is also frequently 
used as it assesses verbal new learning capacity and is sensitive to mild brain 
insults (Gronwall, 1997; White & Proctor, 1997; Bowler et al., 2001). 
 
Some researchers have also utilized measures of executive or frontal lobe 
functioning in their research, such as the commonly used Trail Making Tests A 
and B, the Symbol Digit Modalities Test of written and oral information 
processing and the Controlled Oral Word Association Test of language fluency. 
(White & Proctor, 1997; Gronwall, 1997; Bowler et al., 2001).  
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A variety of reaction time tests have been used to detect any slowed response 
times among chemically injured workers.  The California Computerized 
Assessment Package of Reaction Time has been considered useful in a variety 
of settings, particularly where minor changes in response time are recorded 
(Crowe & Casey, 1999; Shores & Simpson, 1998; Batchelor, Shores & Meares, 
2007). 
 
A number of studies have utilized very lengthy neuropsychological test 
batteries (Chang & Dyer, 1995), while others have used more brief and tailored 
batteries or even just one or two AERP readings such as P300 or P100 in their 
research projects on chemical exposure effects (Teo & Naidu, 1994; Dick et al., 
2001). 
 
The numerous Scandinavian studies on solvent use in the painting and glue 
industries have adhered to their own test batteries, which appear to capture the 
cognitive processes typically affected by toxins, such as formaldehyde, toluene, 
benzene and other hydro carbons such as petroleum fuels (Hagstadius et al., 
1989; Etling et al., 1990). 
 
Fiedler and colleagues used a battery of tests encompassing overall verbal 
ability, spatial relations, concentration and attention, motor skills, visuo-spatial 
skills, memory, sensory and affect in their studies.  They concluded that these 
tests were not significantly sensitive to detect deficits in low level exposures to 
toxins (Fiedler, 1996; Fiedler et al,. 1996). 
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Because so much research has been carried out with petrol and glue sniffers, 
there is now more clear cut evidence as to the actual areas of the brain 
affected by long term use of such neurotoxic substances.  As many deaths 
occur as a result of chronic solvent inhalation, autopsies have been conducted 
on brain matter, so that more exact locations of brain matter destruction can be 
isolated.  Once this knowledge has been obtained, then it is easier to design a 
test battery to assess the functioning of these particular areas.  However, with 
the chemical Glutaraldehyde, there has not been a great deal of research 
carried out, so information on the areas of the brain affected by this chemical is 
limited.  The only reasonable guidelines to follow are those relating to 
formaldehyde, which is a similar member of the aldehyde family of chemicals. 
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CHAPTER  6 
The Establishment of the Test Battery 
6.1  Introduction 
It is because of the above mentioned paucity of research on the chemical 
Glutaraldehyde and its effects on the brain, that the establishment of the test 
battery was a somewhat difficult process. 
 
The first consideration in the selection of tests for inclusion in the research 
project, was to investigate closely the studies already conducted with 
individuals exposed to Glutaraldehyde and the tests which proved most 
sensitive to neurotoxic substances.  In the study undertaken by Gronwall with a 
small group of three health care workers exposed to Glutaraldehyde, all 
participants were found to have information processing speed, concentration 
and memory deficits on the Wechsler Subscales of Digit Symbol, Digit Span 
and Paired Associate Learning (Gronwall, 1997). 
 
A small preliminary clinical study conducted by Coxon, (1999) with four health 
care workers had also demonstrated deficits on the above mentioned tests 
utilized by Gronwall.  These were on the Digit Span, Digit Symbol subtests and 
also Wechsler Memory Scale subtests.  However, deficits in functioning were 
also found in other areas which were tested.  These were in the Trail Making 
Tests A and B, the Reitan Finger Tapping Test and the Grooved Pegboard 
Test.  In addition, there were significantly high levels of anxiety and depression 
found on the Spielberger and Beck Inventories (Coxon, 1999).  
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Although the above mentioned studies were conducted on a very small scale 
with only four participants in each study and there were no control groups for 
comparison, it was considered that the tests utilized in this study, which had 
demonstrated significant deficits, should be included in the test battery for this 
research project. 
 
Other researchers such as Shores & Simpson and Crowe & Casey, suggested 
that reaction time to stimuli was an important factor in research of this nature.  
They had obtained significant findings utilizing subtests of the short form of the 
CALCAP group of tests.  Hence this group of four short subtests of the 
CALCAP Package was included in the test battery (Shores & Simpson, 1998; 
Crowe & Casey, 1999). 
 
In a bid to keep the duration of the test battery as short as possible for ease of 
recruitment of participants, only those tests which were considered to be 
sufficiently sensitive to demonstrate even minor deficits in functioning were 
considered. 
 
As the National Adult Reading Test is used in many research projects as a 
measure of Pre Morbid Intelligence, it was included in the battery of tests as a 
measure of pre-exposure IQ.  The Hospital Anxiety and Depression Scale was 
included as a short but adequate measure of emotional distress (Zigmond, 
1983). 
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Based on the above information, the following battery of tests was selected. 
 
The Test Battery 
Digit Symbol Subtest of WAIS-III 
Digit Span Forwards Test of WAIS-III 
Digit Backwards Test of WAIS-III 
Trail Making Test A 
Trail Making Test B 
Grooved Pegboard Test 
Paired Associate Learning Test of WMS-R 
Controlled Oral Word Association Test 
CALCAP Simple Reaction Time Test 
CALCAP Complex Reaction Time Test 
CALCAP Complex Reaction Time Accuracy 
CALCAP Sequential Reaction Time 1 Test 
CALCAP Sequential Reaction Time 1 - Accuracy 
CALCAP Sequential Reaction Time 2 Test 
CALCAP Sequential Reaction Time 2 - Accuracy  
Hospital Anxiety and Depression Scale 
National Adult Reading Test 
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6.2  Descriptions of Tests 
Digit Symbol Coding 
In this test, a series of numbers is paired with its own corresponding 
hieroglyphic-like symbol using a key and the testee writes the symbol 
corresponding to its number. 
 
The diagnostic value of this subtest has been demonstrated over many years, 
and Matarazzo, (1972) as cited by Tulsky, (2003) was one of the first 
researchers to point out that the Digit Symbol test is not simply a power test, it 
is also related to mental speed.  As such, it is a test in which performance 
declines over time and it is sensitive to a range of clinical conditions such brain 
trauma, dementia and chemical exposure, as outlined by Lezak, (1995). 
 
One reason why the Digit Symbol test is so clinically useful is because there 
are so many reasons for poor performance on the task.  Kaplan et al., (1991) 
as cited by Tulsky, (2003) have listed the various reasons for poor performance 
which are; poor motor coordination, short term memory deficits, visuo- 
perceptual problems, and impaired clerical speed and clerical inaccuracy.  It is 
for these above reasons, and also because neurotoxicity researchers have 
frequently used this sensitive test, that it was included in the test battery.  
 
Digit Span 
The Digit Span Test comprises a series of orally presented number sequences 
that the testee repeats verbatim in Digits Forwards and recites in reverse order 
in Digits Backwards.  Although in the WAIS-III test, the test score is a  
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combination of the forward and the backward components into a single score, 
this study chose to separate them, as they are two very distinctively different 
measures.  Digit Forwards can be successfully executed with simple rote recall, 
while Digit Backwards requires more mental manipulation and the visualisation 
of the numbers (Kaufman & Lichtenberger, 1999).  It is because both these 
components of the Digit Span test assess discrete aspects of attention span 
that they were considered appropriate inclusions in the test battery. 
 
Trail Making Test 
The Trail Making Tests A and B are essentially tests of processing speed or 
psychomotor functioning.  However the Trail Making B component is of greater 
complexity in that it includes an attention shifting or set shifting component 
which is considered to be an executive functioning activity, which engages the 
frontal lobes of the brain (Lezak, 2004). 
 
In the simple Trails A Test, the testee is merely required to connect a series of 
circles in ascending order from 1 to 25 while being timed.   
 
The Trail Making B Test however, requires the individual to commence with the 
number 1, then connect that to the first letter of the alphabet and continue 
alternating numbers and letters until the testee reaches the number 13.  This 
process is also timed. 
 
As the Trail Making Test is a well normed test with good validity and is 
frequently used in neuropsychological assessments internationally, it was   
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included in the test battery.  It is sensitive to frontal lobe dysfunction, and 
therefore is considered relevant for studies on the effects of neurotoxins on the 
brain. 
 
The Grooved Pegboard Test 
The decision to include this test in the battery was made because peripheral 
neurological deficits have often been found among individuals who are 
exposed to neurotoxic chemicals (Lezak, 2004; Coxon, 2002).  This test 
requires the individual to place small metal rods, with round and square sides, 
into a board with matching holes, which are placed in different orientations.  It 
is considered an excellent measure of fine motor skills and is particularly 
sensitive to early cognitive decline. 
 
Paired Associate Learning Test 
This subtest of the Wechsler Memory Scale – Revised (WMS-R), is considered 
to be a good basic measure of capacity for new verbal learning.  It comprises 2 
components, word pairing with simple connections and word pairs which have 
no connection, to assess different levels of new learning capacity. 
 
Controlled Oral Word Association Test 
This assessment is frequently used as a method of measuring verbal fluency 
and also aspects of executive functioning, and was selected due to its 
sensitivity to minor brain insults.  Other researchers have discovered verbal 
dysfluency among individuals who have been exposed to neurotoxic 
substances (Lezak, 2004).  
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Californian Computerized Assessment Package 
This group of tests was selected for its sensitivity to minor brain impairments 
and its usefulness with a range of conditions (Worth et al., 1993; Crowe & 
Casey, 1999; Shores & Simpson, 1998; Batchelor et al., 2007).  Short forms of 
the selected subtests were used in order to reduce the time taken to complete 
the test battery.  The short form had also been used in the above mentioned 
studies. 
 
The group of CALCAP subtests selected were: 
 
Simple Reaction Time Test where the subject is asked to press a computer 
keyboard key when he or she sees anything at all on the screen.  This 
procedure provides a base measure of reaction time. 
 
The Complex Reaction Time Test of visual selective attention requires 
individuals to press a key as soon as they see a specific number, such as “7”, 
on the screen, otherwise they do nothing.  This procedure has a simple 
element of memory,  in addition to reaction time. 
 
The Sequential Reaction Time – 1 which is a serial pattern matching test 
where subjects are asked to press a computer key only when they see two of 
the same number sequences.  For example, when they see a “3” followed by 
another “3”, or a “4” followed by another 4”, they respond by pressing a key.  
This procedure adds a more complex element of memory, since the testee 
must keep in mind the last number that was seen.  
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The Sequential Reaction Time – 2 is a test of serial pattern matching, which 
requires the subject to press a key only when they see two numbers in 
sequence and in ascending order.  For example if they see the number “3” 
followed by the number “4” then they respond, or the number “6” followed by 
the number “7” and so on.  This is the most complex of all the subtests of the 
CALCAP and is considered to be the test most likely to identify impairment 
either in the speed at which the task is executed or the accuracy of the 
response style (Miller, 1995 & 1999). 
 
Hospital Anxiety and Depression Scale 
This scale was included as a means of identifying basic elements of emotional 
distress among participants.  It is a test used originally among hospital patients 
to rapidly assess elements of anxiety and depression which may require 
treatment.  It has 20 Items, 10 of which measure anxiety and 10 of which 
measure depression.  The Hospital Anxiety and Depression Scale (HADS) is a 
self report inventory, which can be answered within a few minutes (Zigmond & 
Snaith,1983).  Mykleton, Stordal & Dahl considered the HADS excellent in 
terms of its factor structure, inter correlation, homogeneity and internal 
consistency, based on data from a large population of 51,930 individuals in 
Norway (Mykleton et al., 2001). 
 
The National Adult Reading Test 
This test is used frequently in the English speaking world to identify an 
individual‟s pre-morbid or pre-injury IQ.  It is based on the principle that the 
capacity to orally read words is established early on in one‟s education and is a  
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skill which is maintained over time, and in spite of brain insults.  This task 
includes 50 words of varying complexity of pronunciation and the testee is 
asked to read each word orally.  A list of correct pronunciations is provided to 
the tester for immediate scoring of the test. (Lezak, 2004). 
 
This test is used very frequently in research studies to estimate changes in IQ 
following an acquired brain injury. 
 
This entire test battery was selected based on the outcomes of previous 
studies and also on the preliminary study with four individuals exposed to 
Glutaraldehyde in their workplaces.  
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CHAPTER  7 
Negotiations with the Australian Nursing Federation 
7.1  Introduction  
Prior to the commencement of the proposed study, permission was sought 
from the Ethics Committee of Murdoch University, to conduct such a study. 
 
The decision of the Ethics Committee was that the study could proceed 
providing the National Body of the nursing profession (The Australian Nursing 
Federation) was involved. 
 
Consequently the Australian Nursing Federation offices in Western Australia, 
South Australia, Victoria and New South Wales were contacted by the 
researcher. 
 
However, the only significant responses were forthcoming from the Western 
Australian and the Victorian Branches. 
 
Submissions were made to both WA and Victorian Central ANF offices and 
these submissions were put to both their Boards for approval. 
 
The Victorian Branch was particularly interested in the project and initiated 
three face-to-face meetings to discuss the parameters and the logistics of the 
study. 
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A group of nurses who had been exposed to Glutaraldehye were invited by the 
ANF (Victoria) to meet with the researcher to discuss test procedures, the 
interview format, test content and the time frame for the research project.   
 
This above mentioned group of nurses offered valuable information regarding 
their history of Glutaraldehyde use and the health issues which had emerged 
for themselves and their colleagues. 
 
Their input was invaluable in the establishment of the Interview for participants, 
in terms of its content and format.  Discussion with these individuals also 
initiated the inclusion of sensitive reaction time and processing speed tests to 
identify any deficits in these particular areas. 
 
The Western Australian Branch of the Australian Nursing Federation agreed to 
participate on the same basis as their Victorian counter parts.  However they 
could not provide office space for testing, so the researcher‟s suburban office 
was used for this purpose. 
 
The Victorian Branch of the ANF made available two offices for testing 
procedures on each of the six visits for the collection of data, for the researcher 
and her research assistants.  The visits usually extended over two or three day 
periods over a two year period. 
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CHAPTER  8 
Recruitment of Participants 
8.1  Participants 
 
Participants were recruited following negotiations with the Australian Nursing 
Federation offices in both Western Australia and Victoria.  Advertisements were 
placed in newsletters in both states advertising the study and providing the 
telephone contact number of the researcher and her supervisor (Appendix A). 
 
When the list of interested individuals was compiled from each state, they were 
allocated into one of the three groups; Experimental Group 1; Experimental 
Group 2 and the Control Group. 
 
Exclusions 
Volunteers were excluded if they suffered any of the following conditions 
Head injury 
Chronic illness 
Under the age of 21 
 
8.2  Group Criteria 
 
Experimental Group 1 
Experimental Group 1 comprised health care workers who had worked with 
Glutaraldehyde for up to 20 years and continued to work with the chemical. 
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Experimental Group 2 
Experimental Group 2 comprised health care workers who had worked with 
Glutaraldehyde for up to 35 years, but no longer worked with the chemical. 
 
Control Group 
The Control Group comprised health care workers who had never worked with 




TABLE  X 
 
Age and Education of Participants 
   
  Exp Group-1  ExpGroup-2  Controls 
  N  =  19  N  =  23  N  =  18 
Age  Mean  =  45  Mean  =  48  Mean  =  42 
 
  Range  (35  ► 63)  Range  (45 ► 64)  Range  (30  ► 62) 
 
Education 
Years  Mean  =  13.4  Mean  =  12.1  Mean  =  12.8 
   
Once the participants were allocated to each of their respective groups, a 
testing schedule was devised. 
 
8.3  Measures 
The  test  measures  used  to  assess  all  participants  were  those  described  in 
Chapter 6 (The Establishment of the Test Battery).  As outlined above, the tests 
were selected for their sensitivity to neurotoxins as indicated in other studies.  
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8.4  Procedure 
The two research assistants who were recruited to assist with the testing 
procedures were both graduate psychologists with experience in research 
processes and the collection of data.  They were trained by the principal 
researcher on the correct administration of each test in the test battery.  There 
were no significant differences between the two research assistants at the time of 
data collection. 
Research Assistant A 
Age:   47 years 
Years of Education:   19 years 
Research Assistant B 
Age:   45 years 
Years of Education:   20 years 
 
The research assistants tested the participants in a randomised manner.  They 
assessed participants from each of the groups at both time 1 and time 2. 
 
Once the volunteer participants from each state were contacted and allocated 
their group placement, the testing procedure commenced. 
 
At the initial session, each participant was asked to sign a “Commitment to 
Participate” form, which was endorsed by the Murdoch University Ethics 
Committee and the Researcher‟s Supervisor.  In signing this document, 
participants agreed that they would participate in the testing procedures 
associated with the study, but could withdraw at any stage should they so wish 
(Appendix B).  
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Once this form was signed and demographic data obtained, an interview was 
conducted to gather information on; participants‟ exposure to Glutaraldehyde; 
the concentration of the Glutaraldehyde used; any protective measures used; 
the symptoms if any, suffered by the participant since Glutaraldehyde exposure; 
and any other health problems they suffered (Appendix B). 
 
The list of symptoms included;  skin rashes; eye irritations; asthma, breathing 
difficulties; headaches; blood nose; stomach cramps; petit mal seizures; fainting 
spells; and chronic sinus infections. 
 
Testing Process 
Following the completion of the clinical interview and the signing of the 
commitment to participate, the psychometric testing procedure commenced.   
 
Each participant was assessed for evidence of anxiety or depression; 
intellectual functioning level; processing speed; problem solving capacity; and 
fine motor skills, via The Test Battery described in Chapter 6.  All scores were 
then entered onto a summary sheet (Appendix B).  All participants were tested 
in the mornings (Test 1 condition) and the evenings (Test 2 condition), to rule 
out the effects of tiredness and the effects of the individuals‟ 24 hours circadian 
rhythms.  The participants were randomly selected for either morning or evening 
testing at their initial assessment session, then tested at the reverse time of day 
on their second assessment session.  Circadian rhythms are considered to be 
possible confounding factors in the neuropsychological assessment of older  
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individuals, as they tend to perform better in the mornings rather than the 
evenings (Stuss, 2008). 
 
Offices were allocated to the researcher and research assistants at 
Headquarters of the Australian Nursing Federation in Melbourne, and in Perth 
the researcher‟s metropolitan office suite was utilized.  The entire testing 
exercise took place over a period of two and a half years and involved eight 
visits to Melbourne to set up the project and test and re-test participants.  The 
visits to Melbourne generally extended over 2 to 3 day periods.  Under certain 
circumstances where it was not possible for the participants to travel to the city, 
visits were made by the research team to rural and semi-rural areas in Victoria.  
The additional time required for the distances travelled extended the data 
collection period beyond its original expectation of one year. 
 
8.5  The Test Battery 
The battery of tests which was administered to all participants in the study was 
selected for its sensitivity to chemical exposure and is described 
comprehensively in Chapter 6.  Test protocols are included in Appendix B. 
The tests included in the Battery which were administered to all participants 
were:- 
The Digit Symbol Subtest of the WAIS-III 
Digit Span Forwards of the WAIS-III 
Digit Span Backwards of the WAIS-III 
Trail Making Test A 
Trail Making Test B  
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Grooved Pegboard Test 
Paired Associate Learning Test of the WMS-R 
Controlled Oral Word Association Test 
CALCAP Simple Reaction Time Test 
CALCAP Complex Reaction Time 
CALCAP Complex Reaction Time Accuracy 
CALCAP Sequential Reaction Time - 1 
CALCAP Sequential Reaction Time - 1 Accuracy 
CALCAP Sequential Reaction Time - 2 
CALCAP Sequential Reaction Time - 2 Accuracy 
Hospital Anxiety and Depression Scale 
 
The duration of the initial testing session was approximately 45 minutes, due to 
the additional time taken for the interview.  The second testing session was of 
approximately 30 minutes‟ duration. 
 
The testing sessions were held from two months to nine months apart, to 
minimise practice effects. 
 
The initial interview information was then rated for risk factors such as; 
frequency and intensity of exposure; the number of protective measures used; 
and exposure to other chemicals or drugs.  A single score was derived from this 
process and this was entered onto summary sheets.  Another appointment was 
then made for the second assessment, which was conducted some months 
later.  
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If the first assessment had been carried out prior to starting work, then the 
second assessment had to be carried out at the end of the individual‟s work 
day.  This was done to rule out the tiredness factor and the impact of Circadian 
Rhythms. 
 
Once all the raw data were collected, the participants‟ results were entered onto 
summary sheets for data analysis.  The three groups‟ summary sheets were 
then colour coded according to their status regarding exposure to 
Glutaraldehyde and their state of origin. 
 
Experimental Groups 1 
Red / Yellow  -  Still working with Glutaraldehyde / Victoria 
Red / Green  -  Still working with Glutaraldehyde / Western Australia 
 
Experimental Groups 2 
Blue / Yellow  -  No longer exposed to Glutaraldehyde / Victoria 
Blue / Green  -  No longer working with Glutaraldehyde / Western Australia 
 
Control Groups 
White / Yellow  -  Never worked with Glutaraldehyde / Victoria 
White / Green  -  Never worked with Glutaraldehyde / Western Australia 
 
It was envisaged initially that the data could be then divided into two groups for 
analysis, Victoria and Western Australia, but due to the low numbers from 
Western Australia, where only 13 participants took part, this was not considered  
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a feasible option.  Therefore all state groups were combined into single groups 
of Experimental 1, Experimental 2 and the Control Group. 
 
Due to the fact that on analysis there were such insignificant differences 
between the Test 1 and Test 2 conditions, the test scores were averaged over 
the two testing times.  This allowed for individuals who had only been able to 
attend one testing session, to have their scores included, by just adding their 
one score. 
 
The absence of these participants at the second testing session occurred 
because some individuals relocated away from their state of origin, or were 
overseas at the scheduled time of the second assessment. 
 
Three participants chose to withdraw from the study and their data was not 
included for analysis.  Two were from Victoria and one was from Western 
Australia.  
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CHAPTER  9 
Results 
9.1  Data Collection and Storage 
All data collected from the three groups of participants was entered onto 
summary sheets for each individual‟s testing sessions. 
These results were then entered onto a Pentium Computer for storage until the 
analysis of the data was carried out. 
The Raw data are presented in (Appendix E). 
 
9.2  Analyses of Results 
All the data were then entered into an Excel program and the means for age 
and education of participants were calculated for the groups individually.  The 
demographics for all these groups of participants are set out below in Table XI. 
TABLE  XI 
Descriptive Summary Statistics 
Overall 
N=58 
Mean (Age) = 49.25 years 
SD (Age) = 7.67 
Range (Age) = 24-64 years 
Mean (Education) = 15.64 years 
SD (Ed) = 2.54 
Range (Ed) = 10-21 years 
 
Experimental Group 1 
N=18 
Mean (Age) = 48.76 years 
SD (Age) = 7.80 
Range (Age) = 31-63 years 
Mean (Education) = 15.35 years 
SD (Ed) = 2.15 
Range (Ed) = 10-19 years 
M (Exposure) = 8.15 years 
SD (Exp) = 5.88 
Range (Exp) = 0.50-20 years 
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Experimental Group 2 
N=23 
Mean (Age) = 50.91 years 
SD (Age) = 6.66 
Range (Age) = 42-64 years 
Mean (Education) = 15.67 years 
SD (Ed) = 2.80 
Range (Ed) = 10-21 years 
M (Exposure) = 11.06 years 
SD (Exp) = 7.34 




Mean (Age) = 47.47 years 
SD (Age) = 8.65 
Range (Age) = 24-58 years 
Mean (Education) = 15.91 years 
SD (Ed) = 2.63 
Range (Ed) = 11-21 years 
 
 
Table XI  details indicate that there were no significant differences between the 
three groups in age or years of education.  However, the participants in 
Experimental Group 2, had a longer range of exposure times to Glutaraldehyde 
than Experimental Group 1  i.e. 3 to 35 years, (Mean 11.06 years) as compared 
with 0.5 to 20 years (Mean 8.15 years).  There were more participants in 
Experimental Group 2, (23) than either of the other groups Experimental Group 
1, = (18) and Control Group, = (17). 
 
The data from the Excel spreadsheet was then entered into the SPSS 15 
program for further analysis.  These data are presented in (Appendix F). 
 
9.2.1  Preliminary investigation of the IQ variables 
The NART provides an indication of pre-morbid IQ, that is, a factor that was 
present prior to the chemical exposure.  Therefore, if the pre-morbid IQ‟s of the  
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3 conditions (Control, E1 & E2) differ significantly from each other, then this 
may have an effect on the scores on the other Dependent Variables (DVs). 
 
A one-way between groups ANOVA, demonstrated that FSIQ differed 
significantly between the different conditions (F (2, 57) = 4.600, p = 0 .014).  
Post hoc multiple comparisons using the Bonferroni Test showed that the 
Control and Experimental 1 Groups differed significantly (p = 0 .013) from one 
another, where the Control Group had a significantly higher mean FSIQ (M = 
119.18) than Experimental Group 1 (M = 114.11).  However, neither group 
differed significantly from Experimental Group 2 (M = 115.74). 
 
As such, differences may be found between the groups on the other DVs as a 
result of differences in their FSIQ rather than differences that are a result of the 
exposure to Glutaraldehyde.  If this were a possibility, then a MANCOVA, could 
have been used which holds the FSIQ factor constant.  However, given there 
are a number of difficulties with this (e.g. unbalanced design – unequal number 
of participants in each group, low sample size for all groups) as well as possible 
difficulties in the NART accurately determining pre-morbid IQ, it was decided 
that the apparent differences in FSIQ are nothing to be overly concerned with.  
In addition, education level is another factor which may have affected the 
Dependent Variables and as such this may need to be considered when looking 
at the overall group differences.  However Table XI indicated that there were no 
significant differences between the three groups in age or education levels.  
Thus given the complexity of the data and the resultant difficulty of assessing it 
with a MANCOVA, it was considered best to tackle this matter from an  
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alternative perspective.  So, for this reason the analysis was continued without 
giving further consideration to FSIQ or ED scores. 
9.2.2  Type of analysis to be used and consideration of dependent 
variables 
Since there were multiple DVs, a Multivariate Analysis of Variance (MANOVA) 
was considered the most appropriate analysis to conduct.  However, the power 
of the MANOVA to detect effects decreases considerably as correlation 
between the DVs increases.  In fact, a number of authors have suggested that it 
is simply wasteful to conduct a MANOVA when a number of the DVs overlap.  
In other words, if there are separate DVs where scores are expected to be very 
similar, it is best not include them in the analysis.  Alternatively, a composite 
score could be created for the DVs which overlap.  Rather than simply 
eliminating measures from the analysis altogether, it was considered better to 
combine the scores of each subtest to produce a composite score for the 
overall test. 
 
Another reason for the necessity of combining the subtest scores rather than 
examine them individually is that, when using MANOVA, there must be more 
cases than DVs in every cell.  Since the lowest sample size of one of the groups 
(the control condition) is 17, there must not be more than 16 DVs.  Even then, 
the assumption of homogeneity of variance-covariance is likely to be rejected if 
there are only one or two more cases than DVs.  Based on the information from 
the thesis proposal regarding groupings of tests, it was decided to only include 
in the analysis the following overall DVs: Digit Symbol, Digit Span, Trail Making, 
CALCAP, PAL, Grooved Pegboard, FAS, Anxiety, and Depression.  
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At this point, it was important to determine whether it was worthwhile to include 
Time as a factor.  If there is not likely to be any difference in test scores from 
Time 1 to Time 2, then these scores should also be combined in order to 
decrease the total number of DVs from 18 to 9 (since, given the sample size, 
there should be no more than 16 DVs and also decreasing the likelihood of the 
assumption of homogeneity of variance-covariance being violated). 
 
An investigatory split-plot ANOVA was conducted (using the Huyn-Feldt Epsilon 
correction for a violation of sphericity) to assess whether it was likely that time 
was an important factor.  This determined that the effect of Time did not differ 
significantly across the subtests (Test Type): F (3.616, 198.890) = 2.075,  
p = 0.092.  In addition, a graphical representation of the Time x Test Type 
interaction suggests there is very little change in score for each test type from 
Time 1 to Time 2 (see Figures 1 and 2 below). 
FIGURE  1 
























































Estimated Marginal Means of MEASURE_1
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Although the SPANOVA suggested that the interaction of time and condition 
was significant (F (2,55) = 5.274, p = 0.008), the figure below should be 
considered: 
FIGURE  2 





































Estimated Marginal Means of MEASURE_1
 
 
This figure shows that scores on the tests decreased quite considerably from 
Time 1 to Time 2 for the Control Group and also for Experimental Group 2 
(although to a lesser extent).  However, scores increased from Time 1 to Time 2 
for Experimental Group1.  Therefore it was not considered a significant enough 
interaction to be representative of anything meaningful.  As discussed, there 
were some participants who were tested at Time 1 and had just finished a night 
shift.  Given that these sorts of factors were not controlled for when determining 
„Time 1‟  and  „Time 2‟, then it is quite probable that there was simply too much 
„noise‟ to be able to take anything from this result. 
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Based on this, it was decided to average the scores for each test at Time 1 with 
those from Time 2.  This enabled the analysis to be „cleaner‟, as well as 
reducing the limitations that the small sample sizes of the groups would have on 
the Doubly Multivariate Analysis that would then need to be conducted (i.e. if we 
included Time as a within-subjects variable). 
 
9.2.3  Assumption testing: Multivariate Normality 
The Shapiro-Wilks test was significant (i.e. indicating a distribution that deviated 
significantly from normal) for: 
 
Experimental Group 1 on the Trails test (p = 0.021), the Control Group on the 
Pegboard test (p = 0.002) and Experimental Group 1 on the Pegboard test  
(p = 0.011). 
 
MANOVA is robust to modest violation of normality if the violation is created by 
skewness rather than outliers.  In addition, the assumption of normality is of less 
concern when the cell size is 30 or more.  Since the sample size here is much 
less, then consideration of this assumption is more critical.  However, looking 
over the distribution plots, it would seem that these violations are due to 
skewness rather than outliers.  As such, it was decided to proceed with the 
analysis with the assumption of multivariate normality confirmed.  However, it 
was considered wise to keep these particular condition-test groups in mind 
before drawing too many conclusions directly from them (i.e. if they turn out to 
be significant).  
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9.2.4  Assumption testing: Homogeneity of variance-covariance 
matrices 
Box‟s Test of Equality of Covariance Matrices was not significant (p = 0.005) at 
an alpha level of .001 and therefore this assumption has not been violated.  
However, the Levene‟s Test of Equality of Error Variances is significant for both 
the Depression and Anxiety tests.  This means that if either of the univariate F-
test is significant for either of these variables, this finding should be interpreted 
at a more conservative alpha level. 
 
9.2.5  Multivariate Tests of Significance: 
There are a number of test statistics that can be used here, but Pillai‟s Trace 
Criterion, was selected since it is considered to have acceptable power and to 
be the most robust statistic against violations of assumptions (of which there are 
some concerns regarding the normality).  As shown in the table below, the 
Pillai‟s Trace Criterion is significant (p = 0.008).  This demonstrates that there 
are significant group differences across the DVs. 
 
TABLE  XII 
Pillai’s Trace Criterion 
 
  Value  F  Hypothesis df  Error df  Sig. 
Pillai'sTrace  0.583  2.192  18.000  96.000  0.008 
 
9.2.6  Univariate Test of Significance: 
This demonstrates which individual DVs contribute to the significant multivariate 
effect.  Since these tests are exactly the same as just running several ANOVAs, 
it is usually advised to use a Bonferroni-type adjustment.  This means that an 
alpha level of  0.006 (.05/9) must be used.  From the table below, it is evident  
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that the groups only differ significantly on the Depression (p = 0.0005) and Digit 
Symbol (p = 0.0005) tests.  However, some researchers choose to ignore this 
safeguard and still use the standard alpha level of .05.  Using this alpha, 
significant effects of Depression (p = 0.0005), Anxiety (p = 0.023), Digit Symbol 
(p = 0.0005) and CALCAP (p = 0.045) were observed.  Although these might be 
accepted as significant, one must be wary that we are risking Type I error (i.e. 
accepting it as significant when it is not). 
 
TABLE  XIII 
 
Dependent Variables which Contribute Significantly 
 
Dependent 
Variable    
Sum of 
Squares  df  Mean Square  F  Sig. 
Observed 
Power(a) 
DEP  Contrast  154.668  2  77.334  8.873  0.000  .965 
   Error  479.371  55  8.716          
ANX  Contrast  97.824  2  48.912  4.021  0.023  .695 
   Error  669.073  55  12.165          
TRAILS  Contrast  1633.825  2  816.912  1.791  0.176  .359 
   Error  25086.730  55  456.122          
FAS  Contrast  1902.564  2  951.282  2.545  0.088  .488 
   Error  20561.682  55  373.849          
PEGBOARD  Contrast  668.457  2  334.229  .991  0.378  .214 
   Error  18548.033  55  337.237          
DIGSYMB  Contrast  3072.241  2  1536.120  9.886  0.000  .979 
   Error  8545.729  55  155.377          
DIGSPAN  Contrast  31.120  2  15.560  1.520  0.228  .310 
   Error  563.155  55  10.239          
PAL  Contrast  42.542  2  21.271  1.953  0.151  .388 
   Error  598.889  55  10.889          
CALCAP  Contrast  415833.362  2  207916.681  3.291  0.045  .601 
   Error  3475086.630  55  63183.393          
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Table XIV  below provides a summary of the individual means of each group for 
each DV.  However, since there are three levels of the group, an examination of 
these means does not indicate which of the levels are significantly different for 
the individual test. 
 




   Condition  Mean  Std. Deviation  N 
DEP  control  1.9412  1.18430  17 
   Exp 1  3.4167  2.59666  18 
   Exp 2  5.8261  3.94453  23 
   Total  3.9397  3.33519  58 
ANX  control  5.0294  2.15400  17 
   Exp 1  5.1389  2.42418  18 
   Exp 2  7.7391  4.74310  23 
   Total  6.1379  3.66801  58 
TRAILS  control  85.6285  14.36815  17 
   Exp 1  98.8767  28.76637  18 
   Exp 2  95.1172  18.72779  23 
   Total  93.5028  21.65137  58 
FAS  control  118.2059  20.57081  17 
   Exp 1  103.5000  15.81046  18 
   Exp 2  111.5652  20.82574  23 
   Total  111.0086  19.85219  58 
PEGBOARD  control  127.0594  13.56203  17 
   Exp 1  134.4558  21.22996  18 
   Exp 2  134.5648  19.00130  23 
   Total  132.3311  18.36114  58 
DIGSYMB  control  77.0000  11.20407  17 
   Exp 1  61.1389  11.79707  18 
   Exp 2  60.9130  13.76974  23 
   Total  65.6983  14.27670  58 
DIGSPAN  control  18.7647  3.30302  17 
   Exp 1  16.9444  2.74338  18 
   Exp 2  17.4348  3.44207  23 
   Total  17.6724  3.22892  58 
PAL  control  24.2941  3.29801  17 
   Exp 1  22.3611  2.41810  18 
   Exp 2  22.4565  3.84623  23 
   Total  22.9655  3.35458  58 
CALCAP  control  1774.3185  256.42991  17 
   Exp 1  1837.1439  247.36978  18 
   Exp 2  1972.3826  250.70129  23 
   Total  1872.3587  261.26951  58  
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9.2.7  Analysis  of  CALCAP  Sub-Tests 
SPSS Variable Names 
SRTa = Average RT between Test 1 & Test 2 on the SRT 
CRTa = Average RT between Test 1 & Test 2 on the CRT 
SEQRT1a = Average RT between Test 1 & Test 2 on the SEQRT1 
SEQRT2a = Average RT between Test 1 & Test 2 on the SEQRT2 
 
Assumption Testing 
All assumptions for the MANOVA were met: 
Shapiro-Wilks test for Normality was significant for Experimental Group 1: SRTa 
and CRTa and Experimental Group 2: CRTa.  Inspection of frequency 
histograms and Q-Q Plots suggests these violations were due to outliers and 
otherwise the distributions appeared normal.  Box‟s Test of Equality of 
Covariance Matrices was not significant (p = 0.008) and therefore this 
assumption is not violated. Levene‟s Test of Equality of Error Variances was not 
significant for any of the conditions. 
 
Multivariate Test of Significance 
As shown in the table below, Pillai‟s Trace Criterion is not significant (p = 0.201). 
This tells us there were not any significant group differences across the scores 
on the CALCAP subtests at a multivariate level.  
TABLE  XV 
 
Pillai’s Trace Criterion 
 
   Value  F  Hypothesis df  Error df  Sig. 
Pillai's Trace  0.192  1.410  8.000  106.000  0.201 
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Univariate Test of Significance 
As described in the previous analysis summary, it is essential for these tests 
that adjustment is made for familywise error (since they are essentially the 
same as running separate ANOVAs).  This means that an alpha level of 0.01 (or 
0.05/4) must be used.  As can be seen in the table below, the SEQRT2a is the 
only subtest that is significant (p = 0.007). 
TABLE  XVI 
 
Subtest Scores and Levels of Significance 
Dependent 
Variable    
Sum of 
Squares  df  Mean Square  F  Sig. 
Observed 
Power(a) 
SRTa  Contrast  4257.813  2  2128.906  .347  0.708  .103 
   Error  337267.904  55  6132.144          
CRTa  Contrast  2288.429  2  1144.215  .213  0.809  .082 
   Error  295421.578  55  5371.301          
SEQRT1a  Contrast  74801.018  2  37400.509  3.402  0.040  .617 
   Error  604698.102  55  10994.511          
SEQRT2a  Contrast  87293.858  2  43646.929  5.488  0.007  .831 
   Error  437462.777  55  7953.869          
 
 
TABLE  XVII 
 
Summary of Subtest Scores for each Group 
 
  Condition  Mean  Std. Deviation  N 
SRTa  Control  338.6765  53.22533  17 
   Exp 1  359.3889  95.15260  18 
   Exp 2  355.3730  79.20705  23 
   Total  351.7255  77.40594  58 
CRTa  Control  403.4218  84.85740  17 
   Exp 1  403.0775  57.48315  18 
   Exp 2  416.0824  75.08656  23 
   Total  408.3355  72.27021  58 
SEQRT1a  control  480.5150  120.06012  17 
   Exp1  493.5861  101.52915  18 
   Exp 2  559.9130  95.06656  23 
   Total  516.0570  109.18350  58 
SEQRT2a  control  551.1471  91.19309  17 
   Exp1  580.6361  102.73569  18 
   Exp 2  642.0870  75.37040  23 
   Total  596.3612  95.94924  58 
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The univariate tests demonstrated that there was only a significant difference 
occurring between the groups within the SEQRT2a subtest.  Therefore it was 
considered necessary to determine where this significant difference was 
occurring.  
 
When pairwise comparisons of the means were observed (using the Bonferroni-
adjustment), it appeared that the only significant difference that was occurring 
was between the Control Group and Experimental Group 2.  That is, 
participants in the Control Group scored significantly lower on average on the 
SEQRT2a than participants in Experimental Group 2 (p = 0.007). 
 
An alternative is to use t-tests for these comparisons.  A Bonferroni-adjustment 
to the alpha level means significance is tested at  0.017 (.05/3).  The results of 
the t-tests were as follows: 
 
Participants in the Control Group scored significantly lower on average on the 
SEQRT2a than participants in Experimental Group 2 (t (38) = -3.450, p = 0.001). 
 
Participants in the Control Group did not score significantly lower on the 
SEQRT2a on average than participants in Experimental Group 1 (t (33) = -
0.896, p = 0.377). 
 
Participants in Experimental Group 1 did not score significantly lower on the 
SEQRT2a on average than participants in Experimental Group 2 (t (39 )= -
2.210, p = 0.033).  In this case the p-value was not significant at the Bonferroni-
adjusted alpha level.  As was mentioned in the previous summary, one may  
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choose to nonetheless assess significance at an alpha level of .05, in which 
case this difference would be significant.  From this one could safely conclude 
that there were significant differences between the Controls on the SEQRT2a 
subtest of the CALCAP and the Experimental Groups.  However, in contrast to 
previous research, there were definitely not any significant differences on the 
other CALCAP subtests. 
 
9.2.8  Length of Exposure 
Due to an interest in comparing short and long-term exposure, an input into 
SPSS was made of the length of exposure for each participant as recorded on 
their Questionnaire. 
 
For Experimental Group 1 (current exposure), the mean length of exposure was 
8.15 years (SD = 5.88).  Length of exposure ranged from 0.5 – 20 years.  The 
frequency of each exposure score can be seen below in Figures 3 and 4.   
                                                 FIGURE  3 
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For Experimental Group 2 (no longer exposed), the mean length of exposure 
was 11.06 years (SD = 7.34).  Length of exposure ranged from 3 - 35 years. 
The frequency of each exposure score can be seen below: 
 
FIGURE  4 
Frequency of Exposure   EXP 2 





















Although the thesis proposal indicated that “short term exposure” would be 
described as exposure of 1 year or less and “long term exposure” was greater 
than one year, there were not sufficient participants to make this division.  That 
is, in the Experimental Group 1 there were only 2 participants with an exposure 
time of 1 year or less and in Experimental Group 2 there were no participants 
who had been exposed for less than one year.  Therefore the division was 
made at a different point to maximize sample size in each group (e.g. 
Short/Medium-term = 8 years or less; Long-term = Greater than 8 years).  
However, this still proved to be too small a sample size to run statistical 
analyses upon.  
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9.3  Summary Analysis of all Results 
Post-hoc multiple comparisons using the Bonferroni test identify significant 
differences for: 
Control (M = 1.94) and Experimental Group 1 (M = 5.83) for Depression 
(p = 0.0005) 
Experimental Group 1 (M = 3.42) and Experimental Group 2 (M = 5.83) for 
Depression (p = 0.036) 
Control (M = 77.00) and Experimental Group 1 (M = 61.14) for Digit Symbol 
(p = 0.001) 
Control (M = 77.00) and Experimental Group 2 (M = 60.91) for Digit Symbol 
(p = 0.001) 
 
It may be useful to note that comparisons are approaching significance for: 
Control (M = 1774.32) and Experimental Group 2 (M = 1972.38) for CALCAP 
(p = 0.051) 
Control (M = 5.03) and Experimental Group 2 (M = 7.74) for Anxiety (p = 0.055) 
 
Alternatively, t-tests could have been used to make post-hoc comparisons.  As 
mentioned earlier, it is generally advisable in this circumstance to make a 
Bonferroni adjustment whereby the alpha level would be set at  0.0042 
(0.05/12).  If this were done then one would see significant differences between: 
 
Control and Experimental Group 2 for Depression (t (38) = -3.920, p = 0.0005) 
Control and Experimental Group 1 for Digit Symbol (t (33) = 4.073, p = 0.0005) 
Control and Experimental Group 2 for Digit Symbol (t (38) = 3.944, p = 0.0005)  
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However, it was decided not to make the Bonferroni-adjustment and therefore 
assess significance by an alpha level of 0.05 (bearing in mind that this could 
lead to potential criticism), then significant t-values were observed for: 
 
Control and Experimental Group 1 for Depression (t (33) = -2.141, p = 0.040) 
Experimental Group 1 and Experimental Group 2 for Depression (t (39) = -2.237, 
p = 0.031) 
Experimental Group 1 and Experimental Group 2 for Anxiety (t (39) = -2.116, 
p = 0.041 
Control and Experimental Group 2 for Anxiety (t (39) = -2.189, p = 0.035) 
Control and Experimental Group 2 for CALCAP (t (38) = -2.446, p = 0.019) 
 
From these post-hoc comparisons, confident interpretations can be made of the 
increase in depression scores for Experimental Group 2 from the Control Group 
and from Experimental Group 1 to Experimental Group 2 (i.e. depression scores 
for Experimental Group 1 did not differ significantly from the Control Group).  In 
addition, it can also be confidently interpreted that the increase in scores on 
Digit Symbol for both Experimental Group 1 and 2 when compared to the 
Control Group.  However they did not differ significantly from one another.  
There could be a “weak” interpretation of the increase in Experimental Group 2 
scores compared to the Control Group for the CALCAP, as well as for the 
increase in anxiety for Experimental Group 2 compared to the Control Group.  
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CHAPTER  10 
Discussion on Glutaraldehyde Study 
10.1  Introduction 
 
One of the most significant results in this study was a significant difference 
between both Experimental Groups 1 and 2 and the Control Group on the Digit 
Symbol scores, which assess processing speed ( P = 0.005). 
 
This outcome demonstrated that the Control Group participants, who had never 
been exposed to the chemical Glutaraldehyde in their workplace, were faster to 
process information than those who had worked with the chemical for some 
years.  The Digit Symbol test of the WAIS-III is considered to be one of the most 
sensitive of all the subtests to many forms of brain insult (Lezak, 2004; Tulsky, 
2003). 
 
The fact that both Experimental Groups‟ scores were significantly lower than 
those of the Control Group on the Symbol Digit test, suggests that their 
processing speed has been affected by their exposure to the Glutaraldehyde in 
their workplace. 
 
As there were no significant education or age differences between the three 
groups, the difference in the scores could not be accounted for by these factors.  
However, there were significant differences in FSIQ between the Controls and 
Experimental Group 1, but not between Controls and Experimental Group 2, yet 
both experimental groups performed more poorly than the Controls on the 
Symbol Digit test.   
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As there were no significant differences in Digit Symbol Test scores between 
Experimental Groups 1 and 2 themselves, (they were both impaired) this 
outcome suggests that exposure to Glutaraldehyde, be it long term or short 
term, current or past, had a significant effect on workers‟ speed of information 
processing. 
 
Another finding was a mildly significant difference between the Control Group 
and Experimental Group 2 scores in the overall CALCAP (California 
Computerized Assessment Package) test of reaction time to stimuli. (P = 0.019).  
However when a breakdown into individual CALCAP subtests was undertaken, 
there was a more significant difference between the Controls and the 
Experimental Group 2 on the most complex of the CALCAP subtests, SEQRT 2.  
This was significant at the level of P = 0.006. 
 
Not only were there significant differences in reaction times between the Control 
Group and Experimental Group 2 participants on the CALCAP test scores, but 
also there was a significant difference between the Control Group and the 
Experimental Group 2 in accuracy of responses in the two most complex 
subtests of the CALCAP, the SEQRT 1 and SEQRT 2 tests. 
 
These two sets of CALCAP data suggested that the Experimental Group 2 were 
both slower to react to the stimuli and also were less accurate in their 
responses to the presented stimuli than the Controls. 
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The Total Interview Score, which estimated the two Experimental Groups‟ 
extent of exposure to Glutaraldehyde and the protective measures used by 
them, indicated that Experimental Group 2 had a significantly greater exposure 
to the chemical than Experimental Group 1.  This may perhaps explain the 
differences between their scores on some of the tests. 
 
The participants in the Experimental Group 2, who no longer worked with 
Glutaraldehyde, appeared to have more significant health problems associated 
with Glutaraldehyde exposure than those in Experimental Group 1, so this could 
also have been a contributing factor to their poor scores.  Unfortunately no data 
was collected on the time which had elapsed since participants in Experimental 
Group 2 ceased working with Glutaraldehyde.  There could well have been 
some recovery effects over these periods of time which were not taken into 
account.  This may have added further significant data to the study. 
 
Regarding the emotional state of the participants; there was a highly significant 
difference between the Control Group and Experimental Group 2 on the 
Depression component of the Hospital Anxiety and Depression Scale (HADS) 
(P = 0.0005).  However the difference between the Control Group and 
Experimental Group 1 on the Depression component was only mildly significant 
(P = 0.04). 
 
On the Anxiety component of the HADS, there was only a mildly significant 
difference between the Control Group and the Experimental Group 2 (P = 0.035) 
and also between the two Experimental Groups 1 and 2 (P = 0.041).  However  
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there were no significant differences between the Anxiety Scores of the Control 
Group and those of the Experimental Group 1. 
 
To summarise, based on the above findings, it can be postulated that 
Experimental Group 2, consisting of participants who had higher levels of 
exposures to Glutaraldehyde and used less protective measures than 
Experimental Group 1, demonstrated slower information processing speed; 
were slower in reaction time to complex stimuli; were more inaccurate in their 
responses to the stimuli presented; had a significantly higher levels of 
depression; and were slightly more anxious than the participants of the Control 
Group. 
 
Surprisingly, Experimental Group 1, who had less severe exposure to 
Glutaraldehyde and used better protective measures than Experimental Group 2 
were equally as slow to process information as the Experimental Group 2 
participants.  However their reaction times to stimuli on the CALCAP tests were 
not significantly slower than those of the Control Group participants, nor were 
they any less accurate in their responses than the Control Group. 
 
10.2  Hypothetical Reasons for Findings 
The findings in this study could reflect the lack of sensitivity of many of the tests 
utilized, where no significant differences were found.  Some of the reaction time 
tests utilized via CALCAP were expected to be sensitive in detecting the effects 
of chemical exposure, as they had been in other studies, but the results were 
only mildly conclusive.  It may be that impairments in cognitive functioning, as  
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measured by the CALCAP reaction time tests are only recognizable when the 
test is complex and the degree of impairment has reached a significantly high 
level.  However the study did reflect the sensitivity of processing speed tests, 
such as Digit Symbol, in determining subtle cognitive impairments in 
Glutaraldehyde exposed workers. 
 
Hence, as Tulsky et al stated “Processing speed tests such as the Symbol Digit 
Coding test, give a more accurate indication of brain impairment, even after only 
mild insults to the brain”.  Therefore it is suggested that any future neurotoxicity 
studies should focus more on this particular dimension of cognitive functioning, 
and perhaps incorporate another WAIS-III component of the Processing Speed 
Index, the Symbol Search test, which was not included in this study (Tulsky et 
al., 2003). 
 
It may be argued that higher levels of depression could account for the poor 
processing speed scores of the two Experimental Groups, when compared to 
participants in the Control Group.  This notion could be refuted on the basis that 
although Experimental Group 2 had very significantly higher levels of 
depression compared with the Control Group (P = 0.005), Experimental Group 
1 had only mildly significant levels of depression compared with the Control 
Group (P = 0.04), yet both Experimental Groups had very significantly impaired 
processing speed scores when compared with the Controls.  Results indicated 
that there was only a mildly significant difference between Experimental Group 
1 and Experimental Group 2 on their HADS Depression scores, (P = 0.036) yet  
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both groups had very significantly slower processing speed scores when 
compared with the Control Group participants (P = 0.0005). 
 
According to researchers Rohling, Green, Allen and Iverson in their 
comprehensive study, depression does not necessarily adversely affect an 
individual‟s cognitive performance.  In their study, there were no significant 
correlations between measures of depression and the various clusters of 
neurocognitive tests administered (Rohling et al., 2002). 
 
It is often considered that where an individual‟s performance is affected by 
depression, it generally has a global effect on all test measures, however in the 
above study, the participants in Experimental Group 1 and Experimental Group 
2  performed reasonably well on most tests, except those which are considered 
to be sensitive to neurotoxic insults, i.e. processing speed and reaction time to 
stimuli.  
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CHAPTER  11 
Critical Evaluation of the Present Glutaraldehyde Study 
11.1  Introduction 
The results of this study demonstrated some significant deficits in processing 
speed for the two Experimental Groups which had been exposed to the 
chemical Glutaraldehyde.  However the only other mildly significant findings 
were those of reaction time to stimuli and accuracy of response to stimuli 
among the Experimental Group 2 participants, when compared with the 
Controls.  This perhaps demonstrates the overall lack of sensitivity of the test 
battery to exposure to chemicals such as Glutaraldehyde. 
 
Perhaps if other speed of information processing speed tests had been 
employed, such as the Symbol Search test of the WAIS-III,  the results may well 
have been more conclusive.  Similarly, more complex reaction time tests could 
have been employed to more closely examine the slowed reaction times of the 
Experimental Groups compared with the Control Group, thereby adding more 
weight to the study. 
 
The Hospital Anxiety and Depression Scale was used as a brief measure of 
emotional distress and did provide some significant and meaningful results for 
Experimental Group 2 on the Depression factor.  However, the anxiety 
component did not demonstrate such differences. 
 
Perhaps if more comprehensive measures of anxiety and depression had been 
utilised, such as the Beck Anxiety Inventory,  the Beck Depression Inventory, or  
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the Personality Assessment Inventory,  then more useful data could have been 
extracted in this domain. 
 
However, in its favour, the above mentioned HADS assessment method was 
selected for ease of obtaining data and the brief time required for test 
administration. 
 
These factors were considered desirable, in the interest of brevity of the test 
battery, as time constraints are a significant factor when limited resources are 
available at the time of data collection. 
 
The researcher was required to travel to Melbourne on a 3 monthly basis over 2 
years to collect the data and also had to fit testing times into the operating hours 
of the Australian Nursing Federation Headquarters in the Melbourne CBD. 
 
For these reasons, it was important that the test battery did not take longer than 
30 to 40 minutes to administer.  In hindsight, a more comprehensive although 
more time consuming test battery, comprising more lengthy, sensitive tests, 
may have provided the researcher with more significant and meaningful data. 
 
However, the above mentioned testing procedures were considered the most 
reasonable ones at the time of the data collection, given all the above mentioned 
constraints.  Consultation had been held with two senior neuropsychology 
academics from New South Wales prior to the establishment of the test battery, to 
ensure that it was appropriate in nature.   
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CHAPTER  12 
Conclusions and Recommendations for Future Research 
12.1  Summary of what was Achieved 
12.1.1  The BAe-146 Study 
The BAe-146 aircraft study of pilots and flight crew exposed to jet engine oil 
emissions via faulty air-conditioning seals, demonstrated impairments in 
information processing speed, concentration and attention span and some 
aspects of memory. 
 
The outcome of this brief study was considered sufficiently concerning to 
warrant a wider scale research project incorporating a larger group of 
participants and a more extensive battery of tests. 
 
The above paper and other more technical papers were presented at the British 
Airline Pilots Association‟s (BALPA) Air Safety and Cabin Air Quality 
International Aero Industry Conference in London in 2005.  Following these 
presentations,  Neuropsychologist,  Dr Sarah Mackenzie-Ross was approached 
by the UK Government to join an advisory committee to investigate the issue of 
ill health among airline pilots exposed to contaminated air.  This Committee on 
Toxicity of Chemicals in Food, Consumer Products and the Environment  (COT) 
is made up of scientists from diverse backgrounds. These are; Molecular 
Toxicology, Pathology, Endocrinology, Epidemiology, Pharmacology, 
Immunology, Nutrition and Neuroscience.  
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The COT was asked to review the available evidence and form an opinion as to 
whether a significant problem existed for airline pilots.  They considered that 
there were only limited data available to enable them to review the situation and 
none of the COT members had any experience in assessing aircraft crew,  
despite submissions being made to COT by the presenters at the BALPA 
International Conference in London in 2005, including that of Coxon (2005). 
However, neuropsychologist, Mackenzie-Ross, who had subsequently 
assessed aircrew in UK for clinical purposes,  was asked to submit her findings 
in a report, as part of their review.  Mackenzie-Ross collaborated with Coxon 
regarding theneuropsychological test battery used in the BAe-146  2002 project. 
 
Among the questions asked of Mackenzie-Ross were: 
How do BAe-146 pilots compare to Boeing 757 pilots? 
Are cabin crew affected? 
Are passengers affected? 
Could ill health be the result of lifestyle and not exposure? 
Any similarities with farmers exposed to Organophosphates? 
 
The above Mackenzie-Ross project was conducted via the University College in 
London, and the results obtained verified those found in the brief Coxon study in 
Western Australia (Coxon, 2002; Mackenzie-Ross, 2006). 
 
Hence the above mentioned Coxon and Mackenzie-Ross projects played a role 
in initiating further research to highlight the difficulties faced by pilots attempting 
to operate aircraft while affected by the inhalation of contaminated air.   
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Further research is likely to be conducted in this important area of workplace 
health and safety in the future.  Already,   air monitors and bleed air cleaning 
technologies are being introduced  to monitor and improve air cabin quality.  
(Rowe, 2007; Aerotoxic Association UK, 2009). 
 
In September 2009, BAe Systems introduced the new “AirManager” air cleaning 
system which it had developed with Quest International.  With the installation of 
this unit, the ventilation air passes through an electric field generated by plasma 
which inactivates viruses, bacteria and mould and oxidises gaseous 
contaminants that contain volatile organic compounds (VOCs), such as ethanol 
and benzene.  This system was touted as a response to fears of SARS, Avian 
Flu, Swine Flu and “market perception” of poor cabin air quality, and was 
installed in the BAe-146 and Boeing 757 aircraft in 2009.  These  were the two 
aircraft with the most frequently reported fume events over the past decade or 
more (Aerotoxic Association Newsletter, October 2009). 
 
12.1.2  F-III Deseal/Reseal Spouse Study 
This study, which investigated the impact on spouses caring for individuals 
affected by neurotoxic chemicals in their workplace highlights the far reaching 
effects of neurotoxicity problems to areas that are beyond those of the workers 
themselves. 
 
Studies such as this give impetus to providers of health and safety programs to 
be more mindful of the extent of the burden of care thrust upon chemically 
affected workers‟ partners and spouses.  Hopefully this will lead to more  
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stringent use of safety measures which are being utilized in all workplaces 
involving chemical exposure, universally. 
 
Such studies may also facilitate the early reporting of chemically induced 
symptoms so that workers do not reach such a disabled state before being 
identified.  This would reduce the enormous burden placed on their carers and 
spouses, which has in the past been largely ignored by employers. 
 
Hopefully the outcomes of this study will also lead employers to provide 
appropriate treatments and respite facilities for the spouses of the affected 
workers who carry the burden of care through no fault of their own. 
 
12.1.3  Glutaraldehyde Study 
 
From this study, it was revealed that lengthy and excessive exposure to the 
chemical Glutaraldehyde, particularly where few protective measures have 
been utilized, can have deleterious effects on the cognitive functioning and the 
emotional state of health care workers handling this chemical. 
 
These effects, although only evident in discrete areas of cognitive functioning, 
such as; speed of information processing, reaction time to stimuli and accuracy 
of responses to stimuli, may have significant effects on the day to day 
performance of such individuals.  In terms of their work performance, they 
would be likely to respond and react more slowly to workplace demands, which 
in emergency situations could prove dangerous, and could render them a 
liability in their work environments.  
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A general slowing of speed of information processing may also render them 
less efficient in their day to day duties, thus wasting valuable time, which is all 
important in modern hospital settings. 
 
On the home front, their inefficiencies could also prove troublesome for other 
family members, especially if they were in a position of responsibility, such as 
taking care of young children, grandchildren or elderly parents. 
 
The Depression scores of the Experimental 2 Group participants which were 
significantly higher than those of  the other two groups, pose two questions  “Do 
their cognitive deficits and health problems cause their depression?”  or  “Does 
their depression contribute to their cognitive dysfunctions?”. 
 
This latter question could essentially be ruled out because the Experimental 1 
Group were not very significantly depressed, yet their reaction times to stimuli 
and their processing speeds were equally as impaired as those of the 
Experimental 2 Group,  who were highly significantly depressed. 
 
This phenomenon was reported in a study by Rohling, Green et al., as 
mentioned previously, where they found non significant correlations between 
measures of depression and various clusters of neurocognitive tests.  This was 
a robust study involving 420 patients with heterogeneous referral diagnoses, 
from head injury to neurological diseases,  plus well-matched non depressed 
control participants.  Contrary to expectation, their data suggested that  
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depression has no impact on objective neurocognitive functioning (Rohling, 
Green et al., 2002). 
 
Future studies in the area of neurotoxicity involving Glutaraldehyde may 
consider employing other more sensitive tests of cognitive functioning ability, 
perhaps those incorporating working memory components.  There was 
evidence of such deficits on one of the CALCAP subtests (SEQR 2) where 
Experimental 2 Group participants were not only the slowest to respond but 
obtained the least accurate scores.  This task requires the individual to hold 
numbers in their memory, while searching for the next consecutive ascending 
number and respond to it as quickly as possible.  If other similar such tasks had 
been included, there may have been a richer bank of data collection for 
analysis. 
 
Another important inclusion for future studies would be a more comprehensive 
collection of details of each group‟s exposure to Glutaraldehyde.  Although this 
information was collected in the present study via questionnaire, there was not 
sufficient detail to provide more useful data. 
 
Although some participants in Experimental Group 2 had provided additional 
information on their questionnaire sheets, this could not be fully utilized as the 
same information had not been extracted from the remaining participants of this 
group.  The information which had been supplied in this manner included; 
descriptions of wide scale chemical spills; faulty equipment which leaked 
chemicals onto the floor; situations where Glutaraldehyde soaked cloths were  
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hung out to dry in the preparation rooms, thus emitting a constant flow of fumes 
into the closed environment; and faulty or non operational extractor fans which 
failed to remove fumes from the sterilizing rooms. 
 
Had this data,  listed above, been extracted from both experimental groups, and 
separated out, then the data obtained may have been reasonably robust and a 
valuable inclusion. 
 
In this study, the history of exposure to Glutaraldehyde; safety measures used; 
and health problems associated with Glutaraldehyde exposure; were all 
combined into an “Exposure History” factor.  Although this appeared to be a 
reasonable approach at the time, in hindsight, it rendered some valuable data 
less useful than it may have been. 
 
Additionally, the study could have been more conclusive, had there been 
greater numbers of participants in each group.  This could have been achieved 
by employing a more comprehensive recruitment campaign using newspaper 
advertisements, or radio programs on community issues.  If more than two 
states in Australia had been included, the study would have been richer in data 
collection and perhaps more meaningful conclusions could have been drawn.  
This would also have enabled state by state comparisons to be made, which 
would have proved useful in terms of national chemical usage and safety 
standards being established on the basis of the results obtained. 
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In this study only Western Australian and Victorian nurses participated, because 
that is where the interest was generated.  The New South Wales and South 
Australia Branches of the Australian Nursing Federation had been contacted, 
but their limited interest did not warrant the collection of data from these states.  
Perhaps if a more personal approach had been made to the Australian Nursing 
Federation offices in South Australia, New South Wales, Queensland and 
Tasmania, then the number of participants could have been doubled or trebled, 
thus creating a richer bank of data. 
 
Funding was also an issue, as the experimenter funded all eight trips to Victoria 
and covered the expenses of both herself and her research assistants.  If a 
substantial grant were to be made in the future to carry out further studies in this 
and similar workplace areas,  then this research project could serve as a very 
useful pilot study. 
 
12.1.4  Research Hypotheses 
 
The research hypotheses of the three above mentioned studies were accepted. 
 
1)  Toxic jet oil emissions from faulty BAe-146 aircraft were found to 
negatively affect the cognitive functioning of pilots and flight crew, 
although the study was limited in its depth and lacked a control group. 
2)  The burden of caring for chronically affected aircraft workers exposed 
to toxins in the RAAF F-III Deseal/Reseal program was found to 
significantly impact on the mental health of their spouses and their 
burden of care was moderate to severe.  
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3)  The occupational exposure of health workers to the chemical 
Glutaraldehyde resulted in some areas of significant cognitive 
impairment and emotional distress. 
 
12. 2  Overall Contributions and Limitations of the Studies 
 
In the area of workplace safety in aviation, hospital and clinic settings, where 
chemicals are used more and more frequently, the outcomes of studies such as 
these highlight the need for stringent health and safety measures to be 
implemented.  Once upper level managers and departmental heads are alerted 
to the long term deleterious effects of chemicals on the cognitive functioning, 
emotional state and overall health of workers and their spouses, one would 
hope that more stringent adherence to recommended guidelines would occur 
across all relevant settings worldwide.  Such recommendations, guidelines and 
warnings are generally clearly outlined by the distributors of toxic products and 
attached to chemical labels.  However, in their haste to dilute and prepare such 
solutions for distribution, as in Glutaraldehyde, staff members have not always 
heeded such guidelines.  Research projects such as these present studies 
highlight the importance of workers adhering to manufacturers‟ 
recommendations, and safety regulations. 
 
Another useful aspect of studies such as these is that the current battery of 
tests, which demonstrated a degree of sensitivity to neurotoxic exposure in 
workers,  could be further refined to include additional more sensitive tests as 
suggested above.  The refined battery could be used with workers in a range of 
other work settings where neurotoxic chemicals are used, as even the current  
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battery of tests has demonstrated a degree of sensitivity to Glutaraldehyde 
exposure in hospitals and clinics, and jet oil fume emissions in the aviation 
industry.  Researchers in the past have also used similar batteries (Gronwall, 
1997; Shores & Simpson, 1998; Mackenzie-Ross, 2006). 
 
If the refined battery which included more sensitive tests, were to be applied to 
a more extensive range of work settings where chemicals are used, then we 
would be able to gather a richer bank of data.  Then if the more sensitive tests 
were to be extracted from the test battery used in these research projects, then 
combined with other test batteries previously used by Mackenzie-Ross, in the 
United Kingdom; Heuser, in USA; Teo, and Coxon, and Winder, in Australia, 
then we may be able to compile a more useful test battery which could be used 
internationally in a variety of work settings, where workers are exposed to 
neurotoxic substances (Mackenzie-Ross, 2006; Heuser, 2005; Teo, 1994; 
Coxon, 2002; Winder, 2005). 
 
Collaboration between all above mentioned groups has already occurred on a 
small scale, but wider scale research needs to occur before such batteries 
could be established and recognized internationally as effective modes of 
assessment. 
 
12.3  Recommendations for Future Research 
In this time of ever increasing use of chemicals in many workplaces, it is of vital 
importance that research projects such as this are ongoing so that any deficits 
in cognitive functioning and health problems are identified at an early stage  
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during the exposure to chemicals.  This would prevent devastating chemical 
injuries from occurring which can maim workers for life, result in their premature 
death, cause health problems for carers and spouses, and create genetic 
problems for future generations (Ford, 1998 &1999; Costa & Manzo, 1998). 
 
However, methods of monitoring environmental and occupational exposures to 
organophosphates, such as chlorpyrifos have their limitations, including low 
specificity and sensitivity, and short time windows for detection.  Unfortunately 
biomarkers for the organophosphate tricresyl phosphate (TCP), which can 
contaminate bleed air from jet engines and cause occupational exposure of 
commercial airline pilots, crew members and passengers, has not to date been 
identified.  However, a research team at the University of Washington‟s 
Department of Medicine led by Kim, Stevens, Furlong et al., have embarked on 
work to identify, purify and characterize new biomarkers of organophosphate 
exposure.  Their hypothesis is that by indentifying and characterising molecular 
biomarkers with longer half lives, they should be able to clinically detect TCP 
and OP insecticide exposure after longer durations of time than are currently 
possible.  This work is necessary and will be ongoing, in order to detect and 
appropriately treat poisonous organophosphate exposures to humans (Kim, 
Furlong et al., 2006). 
 
Hence further research incorporating these highly sensitive testing methods and 
identification of specific biomarkers of organophosphate exposure in humans is 
urgently needed. 
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There is also an important role for neuro imaging, electroencephalograph, 
regional cerebral blood flow and genetic methods of assessment such as; 
SPECT and PET, AERP, rCBF, chromosome testing and ƒMRI, as suggested 
by Heuser & Mena, Teo & Naidu, & Maximilian et al & Ford.  However, these 
are expensive diagnostic tools and their use may be prohibitive if research 
funds are limited (Heuser, 1999: Heuser & Mena, 1998; Teo & Naidu, 1994; 
Maximilian et al., 1982; Ford, 1998, 1999). 
 
A combination of both neuropsychological test data and neuro imaging results 
would no doubt provide more comprehensive and meaningful data as they 
would demonstrate a combination of; pathological changes in brain structure, 
blood flow changes to various parts of the brain, chromosome changes, and 
also functional deficits in brain activity, as revealed by neuropsychological test 
data. 
 
Therefore if neuropsychological, neurological, neuro imaging and other medical 
and genetics researchers could combine their areas of expertise and put effort 
into conducting further research studies, then the effects of a variety of 
frequently used neurotoxic chemicals on the human brain and body would be 
better understood. 
 
We would then have a richer bank of data on which to base more precise safety 
standards, which one hopes would be adhered to in all work settings where 
toxic chemicals are employed.  This hopefully would reduce the casualties 
caused by chemical exposure in workplaces.    
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A number of researchers have raised the issue of under reporting of chemical 
exposure events by workers, particularly those in the aviation industry, where 
air crew fear losing their jobs and pilots licence to fly their aircraft.  Also, the 
industry itself tends not to take “fume events” seriously, as both Rolls Royce 
and British Aerospace have been documented as considering cabin air 
contamination as being associated with “small” or “minor” leakages.  Although 
such events have been documented for almost 20 years, little progress had 
been made in identifying the source of the problem and taking action until 
recent years (Michaelis, 2007). 
 
Hence it is important that workers who are exposed to chemicals in the course 
of their work are properly educated on the dangers associated with such 
chemicals and have access to comprehensive information on the particular 
chemicals they encounter.  It is also important that they have access to 
occupation, health and safety personnel, who are themselves well educated in 
the perils of chemical exposure.  Early reporting of symptoms is all important in 
the treatment of such individuals, as ongoing unreported symptoms can lead to 
permanent health problems, as reported by Costa and Manzo and Hartman 
(Costa & Manzo, 1998; Hartman, 1995). 
 
Following the BALPA Air Safety and Cabin Air Quality Conference in London in 
2005, a group of interested researchers from a range of disciplines and a 
number of countries, gathered together to discuss plans for future research on 
the effects of neurotoxic chemicals on the physical, cognitive, and emotional 
wellbeing of workers, particularly those in the aviation industry.   
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Communication among these groups has been well established for some 4 
years, via internet connection, and hopefully will continue, so that collaboration 
will be ongoing and vital data shared among these concerned researchers.  
Hopefully this will result in changes being made to occupation, health and safety 
legislation internationally, not only to protect humans, but also to protect the 
environment. 
 
Toxico-pathologist,  Professor Vyvyan Howard, who has deep concerns about 
the effects of chemicals on human health and the environment considers that 
we need to take all the precautions we can in preventing harm to humanity and 
the environment,  and quoted in his paper on Risk Assessment, “The 
Precautionary Principle” in 2008. 
“When an activity raises threats of harm to human health or the environment, 
precautionary measures should be taken, even if some cause and effect 
relationships are not fully understood” (Howard, 2008). 
 
Finally, Fengsheng He was also concerned about neurotoxic problems in 
general and proposed: 
 “Although multi-disciplinary research efforts are to be encouraged to investigate 
the pathogenesis, diagnosis and treatment of neurotoxic disorders, it is multi-
sectoral collaboration that is urgently needed if we are to prevent the growth of 
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